Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | P7 - Poster Session 7

Tuesday 04/25/23
08:00 AM - 09:00 AM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG), Practice, Policy, and Ethics
0.00 CME credit

Program Materials Program Evaluations

Event Timeline
08:00 AM - 09:00 AM EST Abstract 9-001 - Expanding Applications of CGRP Modification for Post-traumatic Brain Injury Symptom Control
Dechen Samdrup
08:00 AM - 09:00 AM EST Abstract 9-003 - Symptomatic and Functional Recovery Following Concussion in Adolescents With and Without a History of Psychiatric Disorder
Kiersten Mangold
08:00 AM - 09:00 AM EST Abstract 9-004 - Remotely Supervised tDCS for Persistent Post-Traumatic Headache in Veterans (ReStore)
Leigh Elkins Charvet, PhD
08:00 AM - 09:00 AM EST Abstract 9-005 - A System-wide Retrospective Cohort Analysis of the Development of Psychiatric Conditions Following Concussion
Patrick Brown, MD
08:00 AM - 09:00 AM EST Abstract 9-007 - A Retrospective Analysis of Cannabidiol (CBD) Use in a Concussion Cohort
Daniel Rafie, MD
08:00 AM - 09:00 AM EST Abstract 9-008 - Impact of Return-to-Exercise on Traumatic Brain Injury Recovery in a Community Setting
Ryan Nakamura
08:00 AM - 09:00 AM EST Abstract 9-009 - The Impact of Antithrombotic Agents on In-Patient and Post-Discharge Mortality after Trauma Brain Injury
April DeStefano, MD
08:00 AM - 09:00 AM EST Abstract 9-011 - New-onset Synesthesia and Heightened Creativity in a Musician after Traumatic Brain Injury
Lealani Mae Acosta, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 9-012 - A Rare Case of Traumatic Cervicogenic Exophthalmos: A Case Report
Ye Su, DO
08:00 AM - 09:00 AM EST Abstract 15-001 - The Power of a Post-It: The Reach and Impact of the Twitter Teaching Initiative “#NeuroPostItPearls”
Casey S.W. Albin, MD
08:00 AM - 09:00 AM EST Abstract 15-002 - Neudrawlogy: Simplifying Neurology to Create a Global Social Media Impact
Gabriela Figueiredo Pucci, MD
08:00 AM - 09:00 AM EST Abstract 15-003 - We Don’t Talk About Twitter: The Nuts and Bolts of Social Media for Neurologists
Justin Rosati, MD
08:00 AM - 09:00 AM EST Abstract 15-004 - A Survey-Based Study to Assess Twitter Use by Neurologists Professionally
Aaron Simon Zelikovich, MD
08:00 AM - 09:00 AM EST Abstract 15-005 - Measuring The Impact of a Twitter-Based Educational Initiative: The #EmoryNCCTweetorials Project
Erika Sigman, MD
08:00 AM - 09:00 AM EST Abstract 3-001 - Intranasal Delivery of TGFa – A Novel Therapeutic Approach for Lesion Resolution in Multiple Sclerosis?
Lena *USE ID 377161 Loesslein, PhD
08:00 AM - 09:00 AM EST Abstract 3-002 - Relationship Between Infections and Absolute Lymphocyte Count During Phase 3 and Open-label Extension Trials of Ozanimod in Patients With Relapsing Multiple Sclerosis
Hans-Peter Hartung, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 3-003 - Infusion-Related Reactions With Ocrelizumab: Risk Factors, Symptom Management and Patient Choices in the ENSEMBLE PLUS Study
Robert A. Bermel, MD
08:00 AM - 09:00 AM EST Abstract 3-004 - Retrospective comparison clinical presentation and outcome of Natalizumab and Fingolimod-associated PML
Raphael Bernard-Valnet, MD, PhD
08:00 AM - 09:00 AM EST Abstract 3-005 - Evobrutinib therapeutic response is associated with an increase in the number and maturation of peripheral and central classical dendritic cells
Diego Clemente, PhD
08:00 AM - 09:00 AM EST Abstract 3-007 - Long-term Safety of Ozanimod in Relapsing Multiple Sclerosis and Moderately to Severely Active Ulcerative Colitis
Jon V. Riolo, PhD
08:00 AM - 09:00 AM EST Abstract 3-008 - Rates and Predictors of Serious Infections in MS and NMOSD Patients treated with Anti-CD20 Therapy
Hesham Ahmed Abboud, MD
08:00 AM - 09:00 AM EST Abstract 3-009 - Long-Term Safety and Effectiveness of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice, an updated analysis of the ESTEEM Study
Krupa Shah Pandey, MD
08:00 AM - 09:00 AM EST Abstract 3-010 - Updated Post-Approval Safety of Cladribine Tablets in the Treatment of Multiple Sclerosis, With Particular Reference to Liver Safety
Thomas Leist, MD, PhD, FAAN
08:00 AM - 09:00 AM EST Abstract 3-011 - Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs
John F. Foley, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 3-012 - Comparison of Strategies to Address Hypogammaglobulinemia Secondary to B-cell Depleting Therapies in Neuroimmunology Patients
Hannah Marie Kelly
08:00 AM - 09:00 AM EST Abstract 3-013 - Safety of the Concurrent Administration of Serotonergic Antidepressants and Ozanimod in Patients With Relapsing Multiple Sclerosis
Jennifer L. Reardon
08:00 AM - 09:00 AM EST Abstract 3-014 - Trends and Predictors of Peripheral CD19+ B-cell Repopulation in Patients Treated with Ocrelizumab during COVID-19 Pandemic
Elizabeth Padron, MD
08:00 AM - 09:00 AM EST Abstract 3-015 - Remibrutinib: A Novel BTKi in Development for MS With a Favorable Safety Profile in Various Autoimmune Disorders
Tanuja Chitnis, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 3-016 - Influence of Body Mass Index on B Lymphocyte Repopulation in Multiple Sclerosis Patients Treated with Anti-CD20 Therapy
Jacob Walter Loeffler, MD
08:00 AM - 09:00 AM EST Abstract 3-017 - Symptom stability throughout Ocrelizumab infusion cycle in patients with Multiple Sclerosis: final results of SYMptom Burden on Ocrelizumab, a Longitudinal Study (SYMBOLS)
Ilya Kister, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 3-018 - Improvements in Quality of Life of Patients with Multiple Sclerosis receiving Alemtuzumab in Clinical Practice: LEMVIDA study
Jose Meca Lallana, MD
08:00 AM - 09:00 AM EST Abstract 12-001 - The Value of Clinical Tests in the Diagnosis of Degenerative Cervical Myelopathy: Results of a Systematic Review
Lindsay Tetreault, MD, PhD
08:00 AM - 09:00 AM EST Abstract 12-002 - Diagnostic Accuracy of Somatosensory Evoked Potential monitoring during Scoliosis correction surgery in the pediatric population: A Systematic Review
Vamsi Krishna Gorijala, MBBS
08:00 AM - 09:00 AM EST Abstract 12-003 - “Trident Sign” in Spinal Cord Lymphoma
Kim Griffin, MD
08:00 AM - 09:00 AM EST Abstract 12-004 - The Quix Test: Identifying Vestibular Dysfunction in the "Dizzy Patient"
Kayla Schusterman
08:00 AM - 09:00 AM EST Abstract 12-006 - Assessment of altered mental status in the Emergency Department using quantitative pupillometry: a prospective cohort study
Felix E. Fernandez-Penny, Other
08:00 AM - 09:00 AM EST Abstract 12-007 - Clinical Experience of 'My Sleep' Sleep Digital Recording Application with Web-based Physician Program for Sleep Disorders
Pamela Song, MD
08:00 AM - 09:00 AM EST Abstract 6-001 - Effect of Antiplatelet Therapy in Acute Ischemic Stroke with Tandem Lesions
Mudassir Farooqui, MD
08:00 AM - 09:00 AM EST Abstract 6-002 - Safety Profile of Rescue Stenting Following Thrombectomy for Acute Basilar Artery Occlusion – PC SEARCH Registry Analysis
Ehad Afreen, MD
08:00 AM - 09:00 AM EST Abstract 6-003 - Trends in Thrombectomy Utilization in Stroke: Basilar Artery versus ICA/MCA
Karan Patel
08:00 AM - 09:00 AM EST Abstract 6-004 - In-hospital Delays of Acute Ischaemic Stroke Treatment and Their Influence on Outcomes in Korle Bu Teaching Hospital, Ghana
Fiifi Duodu, MD
08:00 AM - 09:00 AM EST Abstract 6-005 - Clinical outcome in patients with acute hypertensive hemorrhagic stroke with intravenous fluid versus no intravenous fluid: a randomized controlled study
Abhishek Pathak, MD, MBBS, DM
08:00 AM - 09:00 AM EST Abstract 6-006 - Stroke Hospitalization Administration & Monitoring: Routine Or Covid-19 Care (SHAMROCC)
Timothé Langlois-Thérien, Jr., MD
08:00 AM - 09:00 AM EST Abstract 6-007 - Reperfusion Therapy for Acute Ischemic Stroke in Cardiomyopathy Patients with Heart Failure: A National Inpatient Sample-based Analysis
Brittany Russo, MD
08:00 AM - 09:00 AM EST Abstract 6-008 - Racial and Socioeconomic Disparities in Ischemic Stroke Outcomes among Non-lytic/Thrombectomy Patients
Riya Bhavsar, MD
08:00 AM - 09:00 AM EST Abstract 6-009 - System-wide implementation of Computed Tomography Perfusion (CTP) Imaging for Acute Stroke: Impact on Quality, Safety and Outcomes
Nancy Eudalia Abarca, MPH
08:00 AM - 09:00 AM EST Abstract 6-010 - Patient and Hospital Sources of Disparity Predicting Differences in Acute Stroke Treatment in Community and Academic Hospitals
Jerry Shen
08:00 AM - 09:00 AM EST Abstract 6-011 - Addressing the Health Disparities in Acute Ischemic Stroke Outcomes in Africa
Olivier Uwishema
08:00 AM - 09:00 AM EST Abstract 6-012 - Thrombectomy versus tPA in Basilar Artery Occlusion Stroke
Karan Patel
08:00 AM - 09:00 AM EST Abstract 6-013 - Aspirin-Dipyridamole in Fluctuating Small Vessel Disease Ischemic Strokes
Caitlin Moran, MD
08:00 AM - 09:00 AM EST Abstract 6-014 - Treatment of Refractory Vasospasm after Aneurysmal Subarachnoid Hemorrhage: What else could we do for our patients? A Case Report and Systemic Literature Review
Chhitij Tiwari
08:00 AM - 09:00 AM EST Abstract 6-015 - The Effect of Metformin on Stroke Prognosis in Diabetic Patients; a Real World Study
Sara Esmaeili, MD
08:00 AM - 09:00 AM EST Abstract 6-017 - Life-threatening Neutropenia After a Short Course of Dual Antiplatelet Therapy for Minor Stroke
Collin Culbertson, MD
08:00 AM - 09:00 AM EST Abstract 6-019 - 90-Days Outcomes In Patients With Minor Strokes Or Transient Ischemic Attacks Discharged On Single Vs Dual Anti Platelet-Therapy In the Middle East
Hiba Naveed, MD
08:00 AM - 09:00 AM EST Abstract 6-020 - Rivaroxaban for the treatment of cerebral venous thrombosis
Sara Esmaeili, MD
08:00 AM - 09:00 AM EST Abstract 6-021 - Delay of Aspirin Administration in patients after Stroke Code Activation, who are not candidates for tissue Plasminogen Activator (t-PA) or Mechanical Thrombectomy (MT) pre- and post-COVID pandemic.
Muhammad Waseem Anjum, MD
08:00 AM - 09:00 AM EST Abstract 6-022 - Single Center Experience of Intrathecal Nicardipine Use in The Treatment of Vasospasm- Lessons Learned
Aaisha Mozumder, MD
08:00 AM - 09:00 AM EST Abstract 6-023 - An Experience of a Single Comprehensive Stroke Center after Implementation of Routine Tenecteplase Administration for Acute Ischemic Stroke Treatment.
Cara Cawley, DO
08:00 AM - 09:00 AM EST Abstract 6-024 - Cerebral Small Vessel Disease Subtypes and Blood Pressure Control after Intracerebral Hemorrhage
Akashleena Mallick, MD, MBBS
08:00 AM - 09:00 AM EST Abstract 6-025 - Examining the Relationship between Hospital Admission Ischemic Stroke Mortality Score and Hospital Discharge Disposition
Zachary Hodosevich, MD
08:00 AM - 09:00 AM EST Abstract 6-027 - Impact of Circle of Willis Anatomical Variations on Outcomes in Aneurysmal Subarachnoid Hemorrhage
Scott Moody
08:00 AM - 09:00 AM EST Abstract 6-028 - Comparing characteristics and outcomes of in-hospital stroke and community-onset stroke
Zi-Yue Liu
08:00 AM - 09:00 AM EST Abstract 6-029 - Differences in Stroke Outcomes and Experiences between White and Minority Patients and Providers
Nikash Shankar, MD
08:00 AM - 09:00 AM EST Abstract 6-030 - Prophylactic Levetiracetam for the Prevention of Seizures in Acute Nontraumatic Intracerebral Hemorrhage: A Retrospective Propensity-matched Patient Outcome Analysis
Uyen Nguyen
08:00 AM - 09:00 AM EST Abstract 6-031 - Paraneoplastic and non-paraneoplastic limbic encephalitis: distinguishing features and outcomes
Smathorn Thakolwiboon, MD
08:00 AM - 09:00 AM EST Abstract 6-032 - MRI hallmarks of LGI1- and CASPR2-antibody encephalitis
Mark J. Kelly, MBBS
08:00 AM - 09:00 AM EST Abstract 7-001 - Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer’s Disease pathology in Subjective Cognitive Decline.
Giulia Giacomucci
08:00 AM - 09:00 AM EST Abstract 7-002 - Retrospective Cohort Study to Quantify the Economic Impact of Mild Cognitive Impairment
Feride H. Frech, PhD
08:00 AM - 09:00 AM EST Abstract 7-003 - Impact of Incidental Synucleinopathy in Mild Cognitive Impairment due to Alzheimer’s Disease
Jahnavi Shriram
08:00 AM - 09:00 AM EST Abstract 7-004 - Early Neuropsychiatric Symptoms of Mild Cognitive Impairment Subtypes: An Analysis of the National Alzheimer’s Coordinating Center Database
Joseph Eric Malone, MD
08:00 AM - 09:00 AM EST Abstract 7-005 - Subjective cognitive decline: 15 years of follow-up experience from a memory clinic
Salvatore Mazzeo
08:00 AM - 09:00 AM EST Abstract 7-006 - Decentralized approaches in TRAILBLAZER-ALZ 3
Ellen Dennehy
08:00 AM - 09:00 AM EST Abstract 7-007 - Repeat IV and SC Dosing of the Anti-Sortilin Antibody AL101
Balasubrahmanyam Budda, PhD
08:00 AM - 09:00 AM EST Abstract 7-008 - HARBOR: ABBV-916 In Subjects With Early Alzheimer’s Disease Combined Multiple-Ascending Dose/Proof-Of-Concept Study Design
Sagar S Bachhav, PhD
08:00 AM - 09:00 AM EST Abstract 7-009 - Alzheimer’s Disease Linkage to Evidence (AD-LINE) Study Early Results: Linking Real-World Claims Data to Phase III GRADUATE Study of Gantenerumab
Christopher Wallick, PharmD
08:00 AM - 09:00 AM EST Abstract 7-010 - Multi-Modal Correlation Analyses From a Phase 2, Open-Label Study of NE3107 in Patients With Cognitive Decline Due to Degenerative Dementias
Joseph Michael Palumbo, MD
08:00 AM - 09:00 AM EST Abstract 1-001 - Tool to Track Post-Discharge Lab Results Leads to Improved Rates of Follow Up
Olivia Kingsford, DO
08:00 AM - 09:00 AM EST Abstract 1-002 - Tackling resident burn-out through enhancing the work environment amidst the COVID-19 pandemic
Aya A. Ouf, MBBS
08:00 AM - 09:00 AM EST Abstract 1-004 - Assessment of Electronic Medical Record Efficiency in Neurologists
Babar Khokhar, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 1-005 - A Survey of Parental Leave Academic Faculty Experiences Identifies an Overlooked Need
Thy Nguyen, MD
08:00 AM - 09:00 AM EST Abstract 1-006 - A Comparison of the Telemedicine Experience in the Early Pandemic (2020) Vs. Later Pandemic (2021) Periods: Results of a Mixed Methods Comparison
Kelly Ann Pring
08:00 AM - 09:00 AM EST Abstract 10-002 - Sex Differences in Therapy for Myasthenia Gravis
Benjamin Frank Beland, MD
08:00 AM - 09:00 AM EST Abstract 10-003 - Serum Cytokines Levels in Patients with Myasthenia Gravis and Their Changes After Treatment
Doruk Arslan, MD
08:00 AM - 09:00 AM EST Abstract 10-004 - Stimulated Jitter Analysis for the Evaluation of Neuromuscular Junction Disorders in Children
Vishva Natarajan
08:00 AM - 09:00 AM EST Abstract 10-005 - BioDigit MG: A Pilot Study Examining a Digital Technology for Quantitative Assessment and Remote Monitoring of Myasthenia Gravis
Amanda C. Guidon, MD
08:00 AM - 09:00 AM EST Abstract 10-006 - The Impact of Generalized Myasthenia Gravis Severity on Work and Daily Activities: A Real World Study
Jacqueline Pesa, PhD
08:00 AM - 09:00 AM EST Abstract 10-007 - Identifying Digital Biomarkers for the Self-Monitoring of Patients Living with Generalized Myasthenia gravis: a Proof of Concept
Clarissa Gorin, Other
08:00 AM - 09:00 AM EST Abstract 10-008 - A Quantifiable Telemedicine Approach to the Myasthenia Gravis Neurological Exam
Henry J. Kaminski, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 10-009 - Eculizumab for Acetylcholine Receptor-positive Generalized Myasthenia Gravis: Single Center Experience
Hacer Durmus, MD
08:00 AM - 09:00 AM EST Abstract 10-010 - Comorbid Contributors to Fatigue in Myasthenia Gravis
Deep Patel, MD
08:00 AM - 09:00 AM EST Abstract 10-011 - A Quantitative Approach to Telemedicine Assessment of Ptosis and Ocular Motility for Patients with Myasthenia Gravis
Sienna McNett
08:00 AM - 09:00 AM EST Abstract 10-012 - Real World Experience of New MG Therapies: Single Center Cohort Study
Matthew Anderson, DO
08:00 AM - 09:00 AM EST Abstract 10-013 - Myasthenia Gravis Treatments Are Associated with Negative Patient Sentiment in Digital Conversation Data
Jacqueline Pesa, PhD
08:00 AM - 09:00 AM EST Abstract 10-014 - MGBase: The launch of an international electronic database for patients with Myasthenia Gravis
Stephen Reddel, PhD, FRACP, MBBS
08:00 AM - 09:00 AM EST Abstract 4-001 - Real-world Outcomes of Nusinersen or Onasemnogene Abeparvovec (OA) Monotherapy, or Switching to OA from Nusinersen in SMA Patients Aged ≥6 Months
Omar Dabbous, MD
08:00 AM - 09:00 AM EST Abstract 4-003 - Baseline Characteristics and Interim Safety in RESPOND: A Phase 4 Study in Children with Spinal Muscular Atrophy (SMA) Treated With Nusinersen After Onasemnogene Abeparvovec
Nancy L. Kuntz, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-004 - JEWELFISH: 24-month Safety, Pharmacodynamic and Exploratory Efficacy Data in Non-Treatment-Naïve Patients with Spinal Muscular Atrophy (SMA) Receiving Treatment with Risdiplam
Claudia A. Chiriboga, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-005 - Feasibility of a Home-Based Exergame Therapy for Youth with Spinal Muscular Atrophy
Maryam Oskoui, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-006 - Long-Term Follow-Up of Onasemnogene Abeparvovec Gene Therapy in Patients with Spinal Muscular Atrophy Type 1
Jerry R. Mendell, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-007 - Outcomes in Patients with Spinal Muscular Atrophy and Four or More SMN2 Copies Treated with Onasemnogene Abeparvovec: Findings from RESTORE
Richard S. Finkel, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-008 - Bulbar Function in Children with Two or Three SMN2 Copies Who Received Onasemnogene Abeparvovec Presymptomatically for Spinal Muscular Atrophy
Katlyn McGrattan, PhD, SLP
08:00 AM - 09:00 AM EST Abstract 4-009 - FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA)
Basil T. Darras, MD
08:00 AM - 09:00 AM EST Abstract 4-010 - Treatments and Outcomes for Patients with Spinal Muscular Atrophy Type 2: Findings from RESTORE Registry
Laurent Servais
08:00 AM - 09:00 AM EST Abstract 4-011 - Could Ultrasound be a Game Changer in the Diagnosis of Duchenne Muscular Dystrophy? A Systematic Review and Meta-analysis of the Recent Evidence
Mohamed A. Ebrahim, MBBS
08:00 AM - 09:00 AM EST Abstract 4-012 - Sex Differences in Olfactory Spatial Learning in Postnatal Day 13 Mice
Sarah Doebley
08:00 AM - 09:00 AM EST Abstract 13-001 - Self vs machine: clinical and ethical implications of the effects of deep brain stimulation on cognition
Laura De Lima Xavier, MD
08:00 AM - 09:00 AM EST Abstract 13-005 - A Case Based Ethical Approach to Medical Assistance in Dying in Canada for Patient with Cognitive Impairment
Victoria Reedman, MD
08:00 AM - 09:00 AM EST Abstract 13-006 - Racial Disparities in Alzheimer's Disease: the association between early life adversity and AD
Deborah Kathleen Rose, MD
08:00 AM - 09:00 AM EST Abstract 13-007 - Helping Families Make Ethical Choices for Children With Severe Neurological Impairment
Sabrina Kristine Tavella, DO
08:00 AM - 09:00 AM EST Abstract 5-001 - The Effects of Thalamic Deep Brain Stimulation on Gait in Essential Tremor: a Kinematic Study.
Paola Testini, MD
08:00 AM - 09:00 AM EST Abstract 5-002 - Burden of Essential Tremor: Associated Morbidities, Healthcare Resource Utilization and Costs in Commercially Insured Patients on Drug Therapy
Dhira Khosla, DO
08:00 AM - 09:00 AM EST Abstract 5-003 - Serum Neurofilament Light-chain Concentrations in Essential Tremor: A Case-Control Study
Meagen Salinas, MD
08:00 AM - 09:00 AM EST Abstract 5-004 - Tremor Reduction using DBS: Outcomes of a Real-world, Prospective, Multicenter Essential Tremor Registry
Guenther Deuschl, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 5-005 - Investigating synaptic changes in Essential Tremor with PET Imaging
Yanghong Yang
08:00 AM - 09:00 AM EST Abstract 5-006 - Efficacy and Safety of Unilateral MRgFUS Thalamotomy for Essential Tremor
Ka Loong Kelvin Au, MD
08:00 AM - 09:00 AM EST Abstract 5-007 - Therapeutic Outcomes of Directional Deep Brain Stimulation in Essential Tremor Patients
Alina Shub, PA
08:00 AM - 09:00 AM EST Abstract 5-008 - The Impact of Deep Brain Stimulation on the Embarrassment and Self-Esteem of Patients with Essential Tremor
Akanksha Dave, Other
08:00 AM - 09:00 AM EST Abstract 5-009 - Improved electrode configuration for Transcutaneous Afferent Patterned Stimulation for Essential Tremor and Parkinson’s Disease
Alexander Kent, PhD
08:00 AM - 09:00 AM EST Abstract 5-010 - Sleep Disturbances in Early Onset Parkinsonism
Stuart McCarter, MD
08:00 AM - 09:00 AM EST Abstract 5-011 - Neuropathic Symptoms in Parkinson's Disease
Divya Ganugapati
08:00 AM - 09:00 AM EST Abstract 5-012 - Data-Driven Genome-Wide Association Study of Pain Trajectories in Persons with Parkinson's Disease
Shiying Liu
08:00 AM - 09:00 AM EST Abstract 5-013 - Subclinical Liver Fibrosis is Associated with More Rapid Cognitive Decline in Parkinson's Disease
Aryeh Zolin, MD, PhD
08:00 AM - 09:00 AM EST Abstract 5-014 - Pilot Tailored Lighting Intervention on Sleep Disturbances in Parkinson disease
Andrea Sujung Yoo, MD
08:00 AM - 09:00 AM EST Abstract 5-015 - Screening and Treatment of Depression in Parkinson's Disease Within Movement Disorders Centers
James Beck, PhD
08:00 AM - 09:00 AM EST Abstract 2-001 - What trade-offs are patients willing to make when selecting between novel preventive treatments for migraine? Evidence from a Discrete Choice Experiment
Oralee Johnson Varnado, PhD
08:00 AM - 09:00 AM EST Abstract 2-002 - Characterizing the Patient Experience During the Prodrome Phase of Migraine: A Qualitative Study of Symptoms and Their Timing
Krutika Jariwala-Parikh, PhD
08:00 AM - 09:00 AM EST Abstract 2-003 - Autosomal Dominant Trigeminal Neuralgia
Ashley Becker, MD
08:00 AM - 09:00 AM EST Abstract 2-004 - Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment
Neha Kapur
08:00 AM - 09:00 AM EST Abstract 2-005 - Lasting Electrographic Footprint of Familial Hemiplegic Migraine
Mahjabeen Ahmed Khan, MBBS
08:00 AM - 09:00 AM EST Abstract 2-006 - Exploring within-person differences in migraine-associated symptoms across phases of the migraine cycle: Results of the MiCOAS Qualitative Study
James McGinley
08:00 AM - 09:00 AM EST Abstract 2-007 - Characterizing inter- and intra-individual differences in migraine-related cognitive symptoms and impairment across the migraine cycle: An analysis of the MiCOAS qualitative project
James McGinley
08:00 AM - 09:00 AM EST Abstract 2-008 - The relationship between anxiety and depressive symptoms and migraine-related outcomes in children and adolescents: a prospective clinical cohort study
Serena Orr, MD
08:00 AM - 09:00 AM EST Abstract 2-009 - Identifying Areas of Unmet Need Among People with Migraine with an Inadequate Response to Prior Acute Therapies: Results from the MOMENTUM trial
Zachariah Thomas
08:00 AM - 09:00 AM EST Abstract 2-010 - Migraine-Related Stigma in Adults With Current Versus Previous High-Frequency Migraine and Acute Medication Overuse: Results of the Harris Poll Migraine Report Card Survey
Divya Asher
08:00 AM - 09:00 AM EST Abstract 2-011 - Switching from galcanezumab to fremanezumab in migraine patients: a retrospective analysis
Tsubasa Takizawa, MD,PhD
08:00 AM - 09:00 AM EST Abstract 2-012 - Efficacy and tolerability of anti-CGRP monoclonal antibodies in patients aged ≥65 years with episodic or chronic migraine
Sudipa Biswas, MD
08:00 AM - 09:00 AM EST Abstract 11-001 - Glioblastoma as a Herpes Simplex Encephalitis Mimic: A Potential Imaging Trap
Khaled Gharaibeh, MD
08:00 AM - 09:00 AM EST Abstract 11-002 - How much does having a neurologic disease affect QoL in non-CNS cancer patients?
Bernardo Cacho Diaz, MD
08:00 AM - 09:00 AM EST Abstract 11-003 - Barriers to participation in a prospective clinical trial for schwannomatosis-related pain
Scott R. Plotkin, MD, PhD, FAAN
08:00 AM - 09:00 AM EST Abstract 11-004 - Investigating the Molecular Epidemiology and Prognosis of Smoking and Gliomas
Gabriella Marie Bognet, Other
08:00 AM - 09:00 AM EST Abstract 11-005 - Geriatric-8 Assessment is Predictive of Hospitalization in Patients with Glioblastoma
Wade J. Whitt
08:00 AM - 09:00 AM EST Abstract 11-006 - Using Qualitative Interviews to Improve Quantitative Assessments of Quality of Life in Patients with Neurofibromatosis 2
Liesel Von Imhof, Other
Faculty Disclosures
Arseniy Lavrov, MD,PhD Dr. Lavrov has stock in Novartis. Dr. Lavrov has received personal compensation in the range of $100,000-$499,999 for serving as a Executive Medical Director with Novartis Gene Therapies .
Aidan Mullan Aidan Mullan has nothing to disclose.
Kailee White, Other The institution of Miss White has received research support from AbbVie.
Ulind Bejleri, DO Dr. Bejleri has nothing to disclose.
Sneha Mantri, MD Dr. Mantri has received personal compensation in the range of $0-$499 for serving as a Consultant for Deep Brain Innovations, LLC. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grey Matter Technology. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research.
Tiffany Barkley, DO Dr. Barkley has nothing to disclose.
Kathleen Beusterien, Other Ms. Beusterien has received personal compensation for serving as an employee of Cerner Enviza.
Anvita Potluri, MD Dr. Potluri has nothing to disclose.
Dallin Stevens Mr. Stevens has nothing to disclose.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Mihaela Georgieva Mihaela Georgieva has nothing to disclose.
Johanna Therese Fifi, MD, FAAN Dr. Fifi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker, Inc. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serenity. Dr. Fifi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIVI. Dr. Fifi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Fifi has stock in Endostream. Dr. Fifi has stock in Synchron. Dr. Fifi has stock in Imperative Care. Dr. Fifi has stock in Truvic. Dr. Fifi has stock in Bendit. Dr. Fifi has stock in Cerebrotech. Dr. Fifi has stock in Sim&Cure. Dr. Fifi has stock in Q'Apel. The institution of Dr. Fifi has received research support from Viz AI.
Sean J. Pittock, MD Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care.
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Med-IQ. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Everyday Health. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura.
Mitzi Joi Williams, MD, FAAN Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has a non-compensated relationship as a National Board Member with National MS Society that is relevant to AAN interests or activities.
Justin T. Jordan, MD, MPH, FAAN Dr. Jordan has received personal compensation for serving as an employee of City of Beverly. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Dietitians on Demand. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Genesis HR Solutions. An immediate family member of Dr. Jordan has received personal compensation for serving as an employee of Harborlight Montesorri. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Navio Theragnostics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Recursion Pharmaceuticals, Inc. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CEC Oncology. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Texas Health Resources. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Children's Tumor Foundation. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BCD Meetings. Dr. Jordan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shepherd Therapeutics. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michigan State University. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akeila Bio. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Jordan has stock in Navio Theragnostics. Dr. Jordan has stock in The Doctor Lounge. An immediate family member of Dr. Jordan has stock in OldGate. Dr. Jordan has stock in Akeila Bio. The institution of Dr. Jordan has received research support from NIH. The institution of Dr. Jordan has received research support from Department of Defense. The institution of Dr. Jordan has received research support from PCORI. Dr. Jordan has received publishing royalties from a publication relating to health care. Dr. Jordan has received personal compensation in the range of $500-$4,999 for serving as a Reimbursement for potential consultant role that was aborted with Magnet Biomedicine. Dr. Jordan has a non-compensated relationship as a board member with United Council for Neurologic Subspecialties that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a board member with Neurofibromatosis Northeast that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a board member with ABA Academy that is relevant to AAN interests or activities. Dr. Jordan has a non-compensated relationship as a chair, scientific advisory board and board member with Neurofibromatosis Network that is relevant to AAN interests or activities.
Christine Doss Esper, MD, FAAN, FANA Dr. Esper has received research support from Centers for Disease Control and Prevention. Dr. Esper has received publishing royalties from a publication relating to health care.
Aude Maurousset Aude Maurousset has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Aude Maurousset has received personal compensation in the range of $0-$499 for serving as a Consultant for merck. Aude Maurousset has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for roche.
Brian Wideman, DO Dr. Wideman has nothing to disclose.
Jeffrey Zhang Jeffrey Zhang has received personal compensation for serving as an employee of Princeton Pharmatech. Jeffrey Zhang has received stock or an ownership interest from CalciMedica.
Deren Huang, MD Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Mayura Vadhavkar Ms. Vadhavkar has received personal compensation for serving as an employee of Alector. Ms. Vadhavkar has received personal compensation for serving as an employee of Ardelyx. Ms. Vadhavkar has stock in Alector. Ms. Vadhavkar has stock in Ardelyx.
Maya Alexis Miss Alexis has nothing to disclose.
Christopher Wallick, PharmD Dr. Wallick has received personal compensation for serving as an employee of Genentech. Dr. Wallick has stock in Genentech.
Nimish A. Mohile, MD, FAAN Dr. Mohile has nothing to disclose.
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1 Capital, LLC. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cello Health BioConsulting, previously Defined Health. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RAF-5. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Houston NeuroCare. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shire. Dr. Dimachkie has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RaPharma/UCB. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SCHOLAR Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jenssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amazentis / Vandria. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANEM. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme . Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Covance / Labcorp. The institution of Dr. Dimachkie has received research support from CSL Behring. The institution of Dr. Dimachkie has received research support from Orphazyme. The institution of Dr. Dimachkie has received research support from FDA-OOPD. The institution of Dr. Dimachkie has received research support from NIH. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Rocio Carolina Garcia Santibanez, MD, FAAN Dr. Garcia Santibanez has nothing to disclose.
Sarosh R Irani, MD, PhD, FRCP FEAN Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Jessica Helena Goldstein, MD Dr. Goldstein has nothing to disclose.
Ciaran Considine, PhD Dr. Considine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MDisrupt. Dr. Considine has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Park Dietz & Associates. The institution of Dr. Considine has received research support from NIH. The institution of Dr. Considine has received research support from DoD. The institution of Dr. Considine has received research support from Acadia Pharmaceuticals.
James E. Siegler, III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
Maxim Mokin, MD, PhD Dr. Mokin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Mokin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Mokin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Mokin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Mokin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Foley Mansfield.
Sara Hardy, MD Dr. Hardy has received research support from the American Cancer Society.
Yan Defosses, Other Mr. Défossés has nothing to disclose.
Philipp Haselmayer Philipp Haselmayer has received personal compensation for serving as an employee of Merck Healthcare KGaA.
Juliette Narcy Mrs. Narcy has received personal compensation for serving as an employee of Ad Scientiam.
David Herzig, Other Mr. Herzig has received personal compensation for serving as an employee of F. Hoffmann - La Roche AG. Mr. Herzig has stock in F. Hoffmann - La Roche AG. Mr. Herzig has received personal compensation in the range of $5,000-$9,999 for serving as a Lecturer with FHNW.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ACTICOR. Dr. Furie has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Bruce A. C. Cree, MD, PhD, MCR, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. Dr. Cree has received publishing royalties from a publication relating to health care.
Pamela Ng Ms. Ng has received personal compensation for serving as an employee of Research Institute of the McGill University Health Centre.
Carlos Nos, MD Dr. Nos has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann-La Roche Ltd..
Smathorn Thakolwiboon, MD Dr. Thakolwiboon has nothing to disclose.
Pratibha Aia, MD Dr. Aia has nothing to disclose.
Crystal M Proud, MD Dr. Proud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Proud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Proud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta. Dr. Proud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avexis. Dr. Proud has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Proud has received research support from Biogen. The institution of Dr. Proud has received research support from Sarepta. The institution of Dr. Proud has received research support from Avexis. The institution of Dr. Proud has received research support from PTC. The institution of Dr. Proud has received research support from CSL Behring. The institution of Dr. Proud has received research support from Scholar Rock. The institution of Dr. Proud has received research support from Catabasis.
Meghan R. Buzby Mrs. Buzby has received personal compensation for serving as an employee of Coalition for Headache and Migraine Patients. Mrs. Buzby has a non-compensated relationship as a Advisor with Lundbeck that is relevant to AAN interests or activities.
Ashutosh P. Jadhav, MD, FAAN Dr. Jadhav has nothing to disclose.
Joseph E. Safdieh, MD, FAAN Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
Lealani Mae Acosta, MD, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH.
Milagros Galecio-Castillo, MD Dr. Galecio-Castillo has nothing to disclose.
Edip M. Gurol, MD The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer.
Alette Wessels Dr. Wessels has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Wessels has received stock or an ownership interest from Eli Lilly and Company.
Babbel Agbinko-Djobalar, MD Dr. Agbinko-Djobalar has nothing to disclose.
Rizk Alghorazi Mr. Alghorazi has nothing to disclose.
Fred Anderson, PhD Dr. Anderson has nothing to disclose.
Erik Kent St. Louis, MD Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Roy E. Strowd, III, MD, FAAN Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Jose H. Posas, MD, FAAN Dr. Posas has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie.
Jaclyn Martindale, DO Dr. Martindale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Dr. Martindale has received research support from Tourette Association of America. The institution of Dr. Martindale has received research support from American Board of Neurology and Psychiatry.
Thanh Ngoc Nguyen, MD Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vesalio. Dr. Nguyen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Nguyen has received research support from Boston Medical Center. The institution of Dr. Nguyen has received research support from Society of Vascular and Interventional Neurology.
Serena Orr, MD The institution of Dr. Orr has received research support from Alberta Children's Hospital Research Institute. The institution of Dr. Orr has received research support from Canadian Institutes of Health Research. The institution of Dr. Orr has received research support from Department of Pediatrics, University of Calgary. Dr. Orr has received publishing royalties from a publication relating to health care. Dr. Orr has a non-compensated relationship as a associate editor with Headache: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with Neurology that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with American Migraine Foundation that is relevant to AAN interests or activities.
Amy K. Guzik, MD, FAAN Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Brianne Kuns, DO Dr. Kuns has nothing to disclose.
Yousif Gamal Hassan, MD Dr. Hassan has nothing to disclose.
Patrick Furey, Jr. Mr. Furey has nothing to disclose.
Aya Moustafa Aboutaleb, Other Dr. Aboutaleb has nothing to disclose.
Francesco Muntoni, MD Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avexis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Joshua Stodghill, DO Dr. Stodghill has nothing to disclose.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Neeta Garg, MD Dr. Garg has nothing to disclose.
Michel Toledano, MD Dr. Toledano has nothing to disclose.
Andrew McKeon, MD The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Laura M. Scorr, MD Dr. Scorr has received research support from Dystonia Medical Research Foundation.
Alessandro Biffi, MD Dr. Biffi has nothing to disclose.
Rafid Mustafa, MD Dr. Mustafa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics.
Salvatore Mazzeo Mr. Mazzeo has nothing to disclose.
Maryam Oskoui, MD, FAAN Dr. Oskoui has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for the Association des Neurologues du Quebec. The institution of Dr. Oskoui has received research support from Biogen. The institution of Dr. Oskoui has received research support from Roche Genetech. The institution of Dr. Oskoui has received research support from Muscular Dystrophy Canada. The institution of Dr. Oskoui has received research support from Canadian Institutes of Health Research. Dr. Oskoui has a non-compensated relationship as a Member of the Medical and Scientific Advisory Committee with Muscular Dystrophy Canada that is relevant to AAN interests or activities. Dr. Oskoui has a non-compensated relationship as a Member of the External Advisory Board with MDUK Oxford Neuromuscular Centre that is relevant to AAN interests or activities.
Michael G. Benatar, MBChB, DPhil, FAAN Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arrowhead. Dr. Benatar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cartesian. Dr. Benatar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Benatar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Benatar has received intellectual property interests from a discovery or technology relating to health care.
Dechen Samdrup Miss Samdrup has nothing to disclose.
Sunil Sheth, MD Dr. Sheth has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Penumbra. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care.
Mariacristina Scoto Mariacristina Scoto has nothing to disclose.
Neil Avinash Bhathela, MD Dr. Bhathela has nothing to disclose.
Charles J. Duffy, MD, PhD Dr. Duffy has nothing to disclose.
Elias Rizk, MD Dr. Rizk has nothing to disclose.
Seth Thomas Kazmer Mr. Kazmer has nothing to disclose.
Jessica Kobsa Ms. Kobsa has nothing to disclose.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from GE Healthcare. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Anne M. Connolly, MD, FAAN Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Morphic Therapeutics.
Stewart A. Factor, DO, FAAN Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Voyager. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Prelinia. The institution of Dr. Factor has received research support from Medtronics. The institution of Dr. Factor has received research support from Boston Scientific. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Meeryo Choe, MD, FAAN Dr. Choe has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Cases. The institution of Dr. Choe has received research support from NIH. The institution of Dr. Choe has received research support from AIR-P. Dr. Choe has a non-compensated relationship as a Board of Directors with NABIS that is relevant to AAN interests or activities. Dr. Choe has a non-compensated relationship as a Consultant with USA Swimming Concussion Task Force that is relevant to AAN interests or activities.
Neal S. Parikh, MD Dr. Parikh has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for cases of neurological illness. The institution of Dr. Parikh has received research support from Leon Levy Foundation. The institution of Dr. Parikh has received research support from Florence Gould Foundation. The institution of Dr. Parikh has received research support from NY State Empire Clinical Research Investigator Program. The institution of Dr. Parikh has received research support from NIA. The institution of Dr. Parikh has received research support from Medtronic.
Kathryn Leigh Idol Xixis, MD Dr. Xixis has a non-compensated relationship as a Host of Brainstorm! Podcast with Child Neurology Society that is relevant to AAN interests or activities.
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
Hannah Marie Kelly Ms. Kelly has nothing to disclose.
Nazli A. Janjua, MD, MBBS Dr. Janjua has nothing to disclose.
Mitchell Wilson, MD Dr. Wilson has nothing to disclose.
David Chiu, MD Dr. Chiu has nothing to disclose.
Robert A. Bermel, MD Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck Serono. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Jahnavi Shriram Ms. Shriram has nothing to disclose.
Jonathan Perk, MD, PhD, FAAN Dr. Perk has nothing to disclose.
Waldo Guerrero, MD Dr. Guerrero has nothing to disclose.
Jacob Gillen, MD Dr. Gillen has nothing to disclose.
Rachel Gerber Ms. Gerber has nothing to disclose.
Lixin Zhou Lixin Zhou has nothing to disclose.
Marilyn Neault, PhD Dr. Neault has a non-compensated relationship as a Research Patient Advocate with Parkinson's Foundation that is relevant to AAN interests or activities.
Maya Rawal, Other Ms. Rawal has nothing to disclose.
Prince *Use 387204 Pekyi-Boateng, MD Dr. Pekyi-Boateng has nothing to disclose.
Jonathan Haroon Mr. Haroon has nothing to disclose.
Andrew Rava, Other Mr. Rava has received personal compensation for serving as an employee of Genesis Research.
Kelly Ann Pring Ms. Pring has nothing to disclose.
Farhaan S. Vahidy, PhD, MBBS Dr. Vahidy has nothing to disclose.
Ali *use 379793 Samiian, Other Mr. Samiian has received personal compensation for serving as an employee of Cala Health. Mr. Samiian has stock in Cala Health.
Elena Alvarez Rodriguez Elena Alvarez Rodriguez has nothing to disclose.
Valentina Bessi Valentina Bessi has nothing to disclose.
Maureen Smith Ms. Smith has nothing to disclose.
Angela Lee, MD Dr. Lee has nothing to disclose.
Ken Ling No disclosure on file
Justin Rosati, MD Dr. Rosati has nothing to disclose.
Emily Fishman Ms. Fishman has nothing to disclose.
Siyuan Guo, PhD Dr. Guo has nothing to disclose.
Zi-Yue Liu Zi-Yue Liu has nothing to disclose.
Adam T. Mierzwa, MD Dr. Mierzwa has nothing to disclose.
Kevin Cockroft Kevin Cockroft has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Intersocietal Accreditation Commission. The institution of Kevin Cockroft has received research support from Intersocietal Accreditation Commission. The institution of Kevin Cockroft has received research support from Nico Corporation. The institution of Kevin Cockroft has received research support from Idorsia Pharmaceuticals . The institution of Kevin Cockroft has received research support from AstraZeneca .
Giulia Giacomucci Ms. Giacomucci has nothing to disclose.
Yuehui Hong Ms. Hong has nothing to disclose.
Syed F. Zaidi, MD Dr. Zaidi has nothing to disclose.
Enrique Carrazana Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurelis, Alexza, Zogenix. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences. Enrique Carrazana has stock in Neurelis, Marinus, .
Christoph Schroeder No disclosure on file
Elina Zakin, MD The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Jennifer Brons, Other Ms. Brons has nothing to disclose.
Ksenija Gorni Dr. Gorni has received personal compensation for serving as an employee of Hoffman La Roche.
John Oostema John Oostema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Life EMS. The institution of John Oostema has received research support from Spectrum Health. John Oostema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with MDHHS.
Roy Yaari, MD Dr. Yaari has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Yaari has stock in Eli Lilly and Company.
Baldo Toledo, Other Mr. Toledo has received personal compensation for serving as an employee of Sanofi.
Balasubrahmanyam Budda, PhD Dr. Budda has received personal compensation for serving as an employee of Alector. Dr. Budda has received personal compensation for serving as an employee of Acceleron Pharma. Dr. Budda has stock in Alector. Dr. Budda has stock in Acceleron Pharma.
Grant J. Stotts, MD Dr. Stotts has nothing to disclose.
Juergen Gottowik, PhD Dr. Gottowik has received personal compensation for serving as an employee of F. Hoffmann–La Roche Ltd.
Jordan Sheriko, MD The institution of Dr. Sheriko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Sheriko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Sheriko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. The institution of Dr. Sheriko has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Sheriko has received research support from MARS VR Labs. The institution of Dr. Sheriko has received research support from CIHR. The institution of Dr. Sheriko has received research support from IWK Health.
Rajan Ramji Gadhia, MD Dr. Gadhia has nothing to disclose.
Lawrence Korngut, MD Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Angela Paradis Angela Paradis has received personal compensation for serving as an employee of Biogen. An immediate family member of Angela Paradis has received personal compensation for serving as an employee of Biogen. Angela Paradis has received stock or an ownership interest from Biogen. An immediate family member of Angela Paradis has received stock or an ownership interest from Biogen.
Mathias Linnerbauer Mr. Linnerbauer has nothing to disclose.
Christopher Evans, PhD The institution of Dr. Evans has received research support from AbbVie.
Liesel Von Imhof, Other Ms. Von Imhof has nothing to disclose.
Anas Mohammed Alrohimi, MD Dr. Alrohimi has nothing to disclose.
Doruk Arslan, MD Dr. Arslan has nothing to disclose.
John Brandsema, MD Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fibrogen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise. The institution of Dr. Brandsema has received research support from Novartis. The institution of Dr. Brandsema has received research support from Biogen. The institution of Dr. Brandsema has received research support from Alexion. The institution of Dr. Brandsema has received research support from CSL Behring. The institution of Dr. Brandsema has received research support from Pfizer. The institution of Dr. Brandsema has received research support from PTC Therapeutics. The institution of Dr. Brandsema has received research support from Sarepta. The institution of an immediate family member of Dr. Brandsema has received research support from Argenx. The institution of Dr. Brandsema has received research support from Astellas. The institution of Dr. Brandsema has received research support from Fibrogen. The institution of Dr. Brandsema has received research support from Genentech. The institution of Dr. Brandsema has received research support from Janssen. The institution of Dr. Brandsema has received research support from Scholar Rock.
Ralph Lee, ACRP-CP Mr. Lee has received personal compensation for serving as an employee of Irvine Clinical Research. Mr. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Company. The institution of Mr. Lee has received research support from Eli Lilly and Company. The institution of Mr. Lee has received research support from AbbVie. The institution of Mr. Lee has received research support from Acadia. The institution of Mr. Lee has received research support from Biogen. The institution of Mr. Lee has received research support from Eisai. The institution of Mr. Lee has received research support from Green Valley. The institution of Mr. Lee has received research support from Janssen. The institution of Mr. Lee has received research support from Relmada. The institution of Mr. Lee has received research support from Renew. The institution of Mr. Lee has received research support from Roche/Genentech. The institution of Mr. Lee has received research support from Sage. The institution of Mr. Lee has received research support from UCB. The institution of Mr. Lee has received research support from Otsuka.
Matthew Imperioli, MD Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx Pharmaceuticals . Dr. Imperioli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law offices of Scott Doody.
Thanos Tsaktanis, MD Dr. Tsaktanis has nothing to disclose.
Uyen Nguyen Miss Nguyen has nothing to disclose.
Daniel O. Claassen, MD, FAAN Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark . The institution of Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HD Insights. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from Griffin Family Foundation. The institution of Dr. Claassen has received research support from Neurocrine. The institution of Dr. Claassen has received research support from Vaccinex. The institution of Dr. Claassen has received research support from AbbVie. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from Genentech/ Roche. The institution of Dr. Claassen has received research support from Prilenia. The institution of Dr. Claassen has received research support from Neurocrine/ HSG.
Brian Appleby, MD Dr. Appleby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Appleby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ionis. Dr. Appleby has received personal compensation in the range of $0-$499 for serving as a Consultant for Sangamo. The institution of Dr. Appleby has received research support from CJD Foundation. The institution of Dr. Appleby has received research support from Ionis. The institution of Dr. Appleby has received research support from Alector. The institution of Dr. Appleby has received research support from CDC. The institution of Dr. Appleby has received research support from NIH. Dr. Appleby has received publishing royalties from a publication relating to health care. Dr. Appleby has received publishing royalties from a publication relating to health care.
Helen Girma No disclosure on file
Eric Christopher Lawson, MD Dr. Lawson has nothing to disclose.
Ram Kinker Mishra, PhD Dr. Mishra has received personal compensation for serving as an employee of Biosensics.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Anthony Krakovich, MD Dr. Krakovich has received personal compensation for serving as an employee of BMS.
Deep Patel, MD Dr. Patel has nothing to disclose.
Carly Jo Olszewski Ms. Olszewski has nothing to disclose.
Edouard Berling, MD Dr. Berling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adscientiam. Dr. Berling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche.
Erika Sigman, MD Dr. Sigman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Maud Pallix Guyot Maud Pallix Guyot has nothing to disclose.
Mika Naganawa Mika Naganawa has nothing to disclose.
Amber Criswell Mrs. Criswell has nothing to disclose.
Amanda Jones Ms. Jones has received personal compensation for serving as an employee of Axsome Therapeutics. Ms. Jones has received stock or an ownership interest from Axsome Therapeutics.
Ashfaq Shuaib, MD Dr. Shuaib has nothing to disclose.
Aaisha Mozumder, MD Dr. Mozumder has nothing to disclose.
Nabil Wees, MD Dr. Wees has nothing to disclose.
Laura Greenwood, DO Dr. Greenwood has nothing to disclose.
Aiden Liu No disclosure on file
Tricia Tubergen Tricia Tubergen has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic.
Lenora A. Higginbotham, MD The institution of Dr. Higginbotham has received research support from NIH/NINDS . The institution of Dr. Higginbotham has received research support from Bright Focus Foundation. The institution of Dr. Higginbotham has received research support from American Academy of Neurology.
Albert K. Akpalu, MD Dr. Akpalu has nothing to disclose.
Sarah Turgeon Desilets, PT Ms. Turgeon Desilets has nothing to disclose.
Vanessa Merker The institution of Vanessa Merker has received research support from Children's tumor foundation . The institution of Vanessa Merker has received research support from NF Northeast. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a science writer with Neurofibromatosis Network.
Caroline Brethenoux Mrs. Brethenoux has received personal compensation for serving as an employee of Cien+ .
Emily H. Mulvihill, Other Ms. Mulvihill has received personal compensation for serving as an employee of Cerner Enviza, an Oracle Company.
Kunal Agrawal, MD Dr. Agrawal has nothing to disclose.
Bernd C. Kieseier, MD Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis.
Fintan Brian John Sheerin, Other,MBBS Dr. Sheerin has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Indigo Silver Neuroimaging Ltd.
Dina *Use 381078 Mounir, MD,PT Dr. Mounir has nothing to disclose.
Daniel Rafie, MD Dr. Rafie has nothing to disclose.
Jacob Kay, PhD Mr. Kay has nothing to disclose.
Shakti Ramkissoon, MD Dr. Ramkissoon has received personal compensation for serving as an employee of Labcorp. Dr. Ramkissoon has stock in Labcorp.
Can Ebru Kurt Can Ebru Kurt has nothing to disclose.
James Beck, PhD Dr. Beck has received personal compensation for serving as an employee of Parkinson.
Rajesh Pahwa, MD, FAAN Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cala Health. Dr. Pahwa has received personal compensation in the range of $0-$499 for serving as a Consultant for Global Kinetics. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allevion. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Photopharmics. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wren. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Biohaven. The institution of Dr. Pahwa has received research support from Boston Scientific. The institution of Dr. Pahwa has received research support from EIP. The institution of Dr. Pahwa has received research support from Global Kinetics. The institution of Dr. Pahwa has received research support from Amneal. The institution of Dr. Pahwa has received research support from Neuraly. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Pharma 2B. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theranexus. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Voyager. The institution of Dr. Pahwa has received research support from Neuroderm.
Paul Ronksley, PhD Dr. Ronksley has nothing to disclose.
Keiko Ihara Ms. Ihara has nothing to disclose.
Ilya Ayzenberg Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ayzenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Ayzenberg has received research support from Diamed.
Elizabeth Douglas Ms. Douglas has nothing to disclose.
Allison Marie Allen, Other Mrs. Allen has received research support from Parkinson's Foundation. Mrs. Allen has received personal compensation in the range of $500-$4,999 for serving as a COE Site Reviewer with Parkinson's Foundation. Mrs. Allen has received personal compensation in the range of $500-$4,999 for serving as a Speaker with World Parkinson's Coalition.
Nicholas Deconinck Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for avexis. Nicholas Deconinck has received publishing royalties from a publication relating to health care.
Jeremy Michael Kuder, Other Mr. Kuder has nothing to disclose.
Vishnu VY No disclosure on file
Firas Kaddouh, MD Dr. Kaddouh has nothing to disclose.
Robert Fahed, MD Dr. Fahed has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker Neurovascular. Dr. Fahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Yocan Medical Systems.
Zachary Meyer, Other Mr. Meyer has received personal compensation for serving as an employee of Parkinson's Foundation.
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Michael Nussbaum, MD Dr. Nussbaum has nothing to disclose.
Katie Bower, MD Dr. Bower has nothing to disclose.
Farnaz Solatikia, PhD Dr. Solatikia has nothing to disclose.
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
Lauren O'Brien, Other Miss O'Brien has nothing to disclose.
Rajiv Reddy, Other Mr. Reddy has nothing to disclose.
Tiina Drissen, PhD Dr. Drissen has received personal compensation for serving as an employee of Janssen Scientific Affairs LLC. Dr. Drissen has received personal compensation for serving as an employee of Janssen-Cilag Ltd. Dr. Drissen has stock in Johnson & Johnson.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Dubey has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Moffit Cancer Center . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Matthew S. Robbins, MD, FAAN Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, American Academy of Neurology that is relevant to AAN interests or activities.
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for catalyst pharmaceuticals. Dr. Pasnoor has received research support from NIH.
Fawaz Al-Mufti, MD Dr. Al-Mufti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid Medical. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Kelly G. Gwathmey, MD Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Benjamin Frank Beland, MD Dr. Beland has nothing to disclose.
Mark S. Freedman, MD, FAAN Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Aaron Simon Zelikovich, MD Dr. Zelikovich has nothing to disclose.
Andrew D. Warren No disclosure on file
Carmen Ng Carmen Ng has received personal compensation for serving as an employee of Genentech. Carmen Ng has stock in Roche.
April Naegeli, PhD Dr. Naegeli has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Naegeli has stock in Eli Lilly and Company.
Michael Parsons, PhD Dr. Parsons has received publishing royalties from a publication relating to health care.
Margaret Ferguson Margaret Ferguson has received personal compensation for serving as an employee of Eli Lilly. Margaret Ferguson has stock in Eli Lilly.
Zdenek Berger Zdenek Berger has received personal compensation for serving as an employee of Biogen. Zdenek Berger has received personal compensation for serving as an employee of Pfizer. An immediate family member of Zdenek Berger has received personal compensation for serving as an employee of Sanofi. An immediate family member of Zdenek Berger has received stock or an ownership interest from Sanofi. Zdenek Berger has received stock or an ownership interest from Biogen.
Hui Xiong Hui Xiong has nothing to disclose.
Salman Al Jerdi, MD Dr. Al Jerdi has nothing to disclose.
Hwai Yin Ooi, MD Dr. Ooi has nothing to disclose.
Tamara Murphy No disclosure on file
Taylor Marie Wynne No disclosure on file
Brittany Russo, MD Dr. Russo has nothing to disclose.
Ricardo Masson Ricardo Masson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche, Biogen, Avexis. Ricardo Masson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Biogen, Avexis.
Harald Hampel Harald Hampel has received personal compensation for serving as an employee of Eisai Inc..
Kelly E. Lyons, PhD Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Lyons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Dr. Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Parkinson's Foundation. Dr. Lyons has a non-compensated relationship as a President with International Essential Tremor Foundation that is relevant to AAN interests or activities.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/Actelion. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech. The institution of Dr. Bar-Or has received research support from Merck/EMD Serono.
Helene Prigent, MD,PhD The institution of Prof. Prigent has received research support from VLM - Patients association for lysosomial diseases. The institution of Prof. Prigent has received research support from ADEP Assitance.
Manus Donahue Manus Donahue, 13717 has received personal compensation for serving as an employee of Alterity. Manus Donahue, 13717 has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alterity. Manus Donahue, 13717 has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Manus Donahue, 13717 has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Global Blood Therapeutics. Manus Donahue, 13717 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. The institution of Manus Donahue, 13717 has received research support from National Institutes of Health.
Angéline Plaud, PhD Dr. Plaud has received personal compensation for serving as an employee of Ad Scientiam.
Paul Mazaris No disclosure on file
Taylor P. Kuhn, PhD Dr. KUHN has nothing to disclose.
Ashley Ann Martin, PhD Dr. Martin has received personal compensation for serving as an employee of Cerner Enviza. The institution of Dr. Martin has received research support from Lundbeck LLC.
Meliza Roman Ms. Roman has nothing to disclose.
Ersin Tan, MD Dr. Tan has nothing to disclose.
Benjamin Abella No disclosure on file
Aziz I. Shaibani, MD, FAAN Dr. Shaibani has nothing to disclose.
Husam Al Sultani Husam Al Sultani has nothing to disclose.
Richard S. Finkel, MD, FAAN Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Stephen Reddel, PhD, FRACP, MBBS Dr. Reddel has nothing to disclose.
Doug Gunzler Doug Gunzler has received publishing royalties from a publication relating to health care.
Wade J. Whitt Mr. Whitt has nothing to disclose.
Alvin Das, MD Dr. Das has nothing to disclose.
Alina Shub, PA The institution of Ms. Shub has received research support from Abbott and Boston Scientific .
Nadeem I. Khan, MD Dr. Khan has nothing to disclose.
Katlyn McGrattan, PhD, SLP Dr. McGrattan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. McGrattan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech.
Ernst Mayerhofer, MD Dr. Mayerhofer has nothing to disclose.
Marina *Use 361162 Ziehn, PhD Dr. Ziehn has received personal compensation for serving as an employee of Novartis AG.
Hea Ree Park Hea Ree Park has nothing to disclose.
Christopher D. Anderson, MD,PhD, FAAN The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Charles David McCane Mr. McCane has nothing to disclose.
Serena Wong, MD Dr. Wong has nothing to disclose.
Oleg Y. Chernyshev, MD, PhD, FAAN Dr. Chernyshev has nothing to disclose.
Abdulrahman Ayman Ebrahim Mr. Ebrahim has nothing to disclose.
Jiangyong Min, MD Dr. Min has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott . Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic .
Katherine Buzzard, PhD, FRACP, MBBS Dr. Buzzard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Buzzard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Buzzard has received personal compensation in the range of $5,000-$9,999 for serving as a support to attend educational conference with Roche.
Alexander Kent, PhD Dr. Kent has received personal compensation for serving as an employee of Cala Health. Dr. Kent has stock in Cala Health. Dr. Kent has received intellectual property interests from a discovery or technology relating to health care. Dr. Kent has received intellectual property interests from a discovery or technology relating to health care.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Anna Naito Anna Naito has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Parkinson's Foundation.
Xin Ying Lee, Other Ms. Lee has received personal compensation for serving as an employee of Lundbeck A/S.
Carolina A.E. Rush, MD Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm . Dr. Rush has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi .
Ivan Bozin Dr. Bozin has received personal compensation for serving as an employee of Biogen. Dr. Bozin has received personal compensation for serving as an employee of Arvelle Therapeutics. Dr. Bozin has stock in Biogen.
Dima Hisham Fikry, Other Dr. Fikry has nothing to disclose.
Bruno Brochet, MD, FEAN Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Arvin Parvathaneni, MD Dr. Parvathaneni has nothing to disclose.
Mohamed Elkasaby, MD Dr. Elkasaby has nothing to disclose.
Cenai Zhang, Other Miss Zhang has nothing to disclose.
Shahrose Aratia, Other Ms. Aratia has nothing to disclose.
Jeffrey Holloway, MD Dr. Holloway has nothing to disclose.
Casey S.W. Albin, MD Dr. Albin has received personal compensation in the range of $0-$499 for serving as a Consultant for Azurity Pharmaceutical. Dr. Albin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum: Life Long Learning in Neurology. Dr. Albin has received research support from American Academy of Neurology. Dr. Albin has received publishing royalties from a publication relating to health care. Dr. Albin has received personal compensation in the range of $500-$4,999 for serving as a Instructor with Resuscitation Leadership Academy.
Harini Sarva, MD Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Covance. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial.
Lyell K. Jones, MD, FAAN Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a member of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Janis Miyasaki, MD, FAAN Dr. Miyasaki has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Miyasaki has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Miyasaki has received research support from PCORI. The institution of Dr. Miyasaki has received research support from Brain Canada. The institution of Dr. Miyasaki has received research support from Canadian Consortium on Neurodegeneration in Aging. The institution of Dr. Miyasaki has received research support from University Hospital Foundation. The institution of Dr. Miyasaki has received research support from Social Science and Health Research Council.
Steven M. Greenberg, MD, PhD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Washington University/IQVIA. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Greenberg has received research support from National Institutes of Health. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Muhib Khan, MD, FAAN The institution of Dr. Khan has received research support from NINDS. The institution of Dr. Khan has received research support from Genentech. The institution of Dr. Khan has received research support from Spectrum Health-MSU alliance. Dr. Khan has received research support from NIH.
Gabor Toth, MD Dr. Toth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Toth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic.
Nancy Eudalia Abarca, MPH Miss Abarca has nothing to disclose.
Ivan Nikolaev, MD Dr. Nikolaev has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Nikolaev has stock in Novartis Pharma AG.
Ursula Boschert Shafaatian Ursula Boschert has nothing to disclose.
Albert J. Yoo, MD,PhD Dr. Yoo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Penumbra. Dr. Yoo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Yoo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Philips. Dr. Yoo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Yoo has stock in Insera Therapeutics. Dr. Yoo has stock in Galaxy Therapeutics. Dr. Yoo has stock in Nicolab. The institution of Dr. Yoo has received research support from Medtronic. The institution of Dr. Yoo has received research support from Cerenovus. The institution of Dr. Yoo has received research support from Penumbra. The institution of Dr. Yoo has received research support from Stryker. The institution of Dr. Yoo has received research support from Genentech. Dr. Yoo has a non-compensated relationship as a consultant with Vesalio that is relevant to AAN interests or activities. Dr. Yoo has a non-compensated relationship as a consultant with Zoll Circulation that is relevant to AAN interests or activities.
Tamar Bacon An immediate family member of Tamar Bacon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. An immediate family member of Tamar Bacon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of an immediate family member of Tamar Bacon has received research support from Gentech. The institution of an immediate family member of Tamar Bacon has received research support from Novartis. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Konstantin E. Balashov, MD, PhD, FAAN Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Griet Loret, MD Dr. Loret has nothing to disclose.
Dinesh Pashankar, MD Dr. Pashankar has nothing to disclose.
Silvio Danese Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Alimentiv. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Applied Molecular Transport. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for AstraZeneca. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Athos Therapeutics. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Myers Squibb. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Celltrion. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Dr Falk Pharma. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Enthera. Prof. Danese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferring Pharmaceuticals Inc. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Gilead. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Inotrem. Prof. Danese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Johnson & Johnson. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Morphic. Prof. Danese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Prof. Danese has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Prof. Danese has received personal compensation in the range of $0-$499 for serving as a Consultant for Teladoc Health.
Janine Lemos Melo Lobo Jofili Lopes No disclosure on file
Nancy L. Kuntz, MD, FAAN Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Affinia Therapeutics. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta.
Ivan Jurisic, Other Mr. Jurisic has received personal compensation for serving as an employee of Roche.
Sarah Cawley Miss Cawley has nothing to disclose.
Michael Joseph Diaz, Other Mr. Diaz has nothing to disclose.
Diego Clemente, PhD The institution of Dr. Clemente has received research support from EMD Serono Research & Development Institute, Inc.. The institution of Dr. Clemente has received research support from Bristol Myers Squibb. The institution of Dr. Clemente has received research support from Instituto de Salud Carlos III. Dr. Clemente has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of Grants with Spanish National Investigation Agency.
Shivangi *use 121636 Vora No disclosure on file
Nancy E. Bass, MD Dr. Bass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elseviert.
Eddie Stage, PhD Dr. Stage has received personal compensation for serving as an employee of AbbVie. Dr. Stage has stock in AbbVie..
Giulia Galdo, MD Dr. Galdo has nothing to disclose.
Abid Qureshi, MD Dr. Qureshi has nothing to disclose.
Nameer Aladamat, MBBS Dr. Aladamat has nothing to disclose.
Gang Li, PhD Dr. Li has received personal compensation for serving as an employee of Eisai Inc.
Collin Jakubecz, Other Dr. Jakubecz has nothing to disclose.
Sarah Harris Sarah Harris has received personal compensation for serving as an employee of BMS. Sarah Harris has stock in BMS.
Babar Khokhar, MD, FAAN Dr. Khokhar has nothing to disclose.
Alexander Andreev, MD Dr. Andreev has nothing to disclose.
Olga Alekseeva, Jr., MD Prof. Alekseeva has nothing to disclose.
Dariush Dowlatshahi, MD Dr. Dowlatshahi has nothing to disclose.
Krutika Jariwala-Parikh, PhD Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.
Laura Gonzalez Quijano, Other Miss Gonzalez Quijano has nothing to disclose.
David Matuskey, MD Dr. Matuskey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Eleisver. The institution of Dr. Matuskey has received research support from Abbvie.
Yuhui Sha Ms. Sha has nothing to disclose.
Sarbjit Saini, MD Dr. Saini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Saini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Graular. Dr. Saini has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for AAAAI. Dr. Saini has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for AAAAI. Dr. Saini has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UptoDate. The institution of Dr. Saini has received research support from Novartis. The institution of Dr. Saini has received research support from Sanofi. The institution of Dr. Saini has received research support from Regenron.
John A. Brooks, MD No disclosure on file
Jeffery R. Balzer No disclosure on file
Dominic Jack Dominic Jack has received personal compensation for serving as an employee of Merck KGaA, Darmstadt, Germany.
Beth Potter, PhD The institution of Dr. Potter has received research support from Cambrooke Ajimoto. The institution of Dr. Potter has received research support from Nutricia. The institution of Dr. Potter has received research support from Biomarin.
Eun-Yeon Joo, MD Dr. Joo has nothing to disclose.
Satinderpal Singh, DO Dr. Singh has nothing to disclose.
Steven Kymes Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Tracy Van, Other Miss Van has nothing to disclose.
Bonaventura Casanova Bonaventura Casanova has nothing to disclose.
Eduardo Tizzano Eduardo Tizzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Eduardo Tizzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis Novartis.
Juan A. Vivanco-Suarez, MD Mr. Vivanco-Suarez has nothing to disclose.
Michihiro Hide, MD,PhD Dr. Hide has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teikoku Seiyaku. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kaken Pharmaceutical. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa-Kirin. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Taiho. Dr. Hide has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyorin. The institution of Dr. Hide has received research support from Japan and Grant-in-Aid for Scientific Research.
Walter Toro Walter Toro has received personal compensation for serving as an employee of Astellas. Walter Toro has received personal compensation for serving as an employee of Avexis. Walter Toro has received personal compensation for serving as an employee of Novartis Gene Therapies.
Cederic M. Pimentel, MD Dr. Pimentel has nothing to disclose.
Eugene Nelson No disclosure on file
Svetlana Petkun Svetlana Petkun has received personal compensation for serving as an employee of Hoffmann-La Roche Inc..
Lester Y. Leung, MD Dr. Leung has received research support from NIH.
Kevin Bickart, MD, PhD Dr. Bickart has nothing to disclose.
Alex Lorenzo Mr. Lorenzo has nothing to disclose.
Jacob Walter Loeffler, MD An immediate family member of Dr. Loeffler has received research support from National Science Foundation. The institution of an immediate family member of Dr. Loeffler has received research support from Amazon.
Artem Zharkov, MD Dr. Zharkov has received personal compensation for serving as an employee of Novartis. Dr. Zharkov has received personal compensation for serving as an employee of Roche. An immediate family member of Dr. Zharkov has received personal compensation for serving as an employee of SOBI. Dr. Zharkov has stock in Novartis.
Steven Alexander Gunzler, MD, FAAN Dr. Gunzler has received research support from NIH/NINDS. The institution of Dr. Gunzler has received research support from Biogen. The institution of Dr. Gunzler has received research support from Amneal. Dr. Gunzler has received research support from Michael J Fox Foundation.
Kathy Selby, MD The institution of Dr. Selby has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Selby has received research support from Biogen . The institution of Dr. Selby has received research support from Italfarmico. The institution of Dr. Selby has received research support from Reverogen.
Amy Brown, MD Dr. Brown has nothing to disclose.
Sheila Seleri Sheila Seleri has received personal compensation for serving as an employee of Genentech, a member of the Roche group. Sheila Seleri has stock in Genentech, a member of the Roche group.
Michael Ward Michael Ward has received personal compensation for serving as an employee of Alector. Michael Ward has stock in Alector. Michael Ward has received intellectual property interests from a discovery or technology relating to health care. Michael Ward has a non-compensated relationship as a Reviewer with ADDF that is relevant to AAN interests or activities.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Motric Bio.
Jay Patel, MD No disclosure on file
Jee Hyun Kim, MD, PhD Dr. Kim has nothing to disclose.
Zahra Mirzaasgari, MD Dr. Mirzaasgari has nothing to disclose.
Melissa Wigderson Dr. Wigderson has received personal compensation for serving as an employee of Novartis Gene Therapies. Dr. Wigderson has stock in Novartis.
Liliana Gil Valletta, Other The institution of Mrs. Gil Valletta has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Janssen. The institution of Mrs. Gil Valletta has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for A- Speakers. The institution of Mrs. Gil Valletta has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for The Cleveland Clinic. Mrs. Gil Valletta has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for United Health Group. Mrs. Gil Valletta has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Zumiez.
Hesham Ahmed Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. Dr. Abboud has received publishing royalties from a publication relating to health care.
Naoki Miyazaki Mr. Miyazaki has nothing to disclose.
Nobuyuki Takahashi, MD Dr. Takahashi has nothing to disclose.
Scot Styren No disclosure on file
Giovanni Baranello Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AveXis. The institution of Giovanni Baranello has received research support from Great Ormond Street Hospital Charity.
Jessica Abramson No disclosure on file
Claudio Bruno Claudio Bruno has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Claudio Bruno has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Claudio Bruno has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Douglas Bernhard Douglas Bernhard has nothing to disclose.
Michael George Abraham, MD Dr. Abraham has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker Neurovascular.
Mehdi Maghbooli, MD Dr. Maghbooli has nothing to disclose.
Khaled Ashraf Mohamed Mr. Mohamed has nothing to disclose.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Meagen Salinas, MD The institution of Dr. Salinas has received research support from North Texas VA Health Care System New Investigator Award.
Lawrence Steinman, MD, FAAN Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Axana Rodriguez-Torres No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Mohamad Abdalkader Mohamad Abdalkader has nothing to disclose.
Jun Ni Jun Ni has nothing to disclose.
Roberto P. Ortega, MD No disclosure on file
Maggie Markgraf Ms. Markgraf has nothing to disclose.
Jonathan Rosand, MD Dr. Rosand has received personal compensation for serving as an employee of Massachusetts General Hospital. Dr. Rosand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rosand has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for National Football League. The institution of Dr. Rosand has received research support from NIH. The institution of Dr. Rosand has received research support from American Heart Association. Dr. Rosand has received personal compensation in the range of $0-$499 for serving as a Peer reviewer with National Institutes of Health. Dr. Rosand has a non-compensated relationship as a Trustee with Columbia University that is relevant to AAN interests or activities.
Eleanor Grant, PhD Dr. Grant has nothing to disclose.
Corinne Makepeace Corinne Makepeace has nothing to disclose.
Aryeh Zolin, MD, PhD Dr. Zolin has nothing to disclose.
Chun-Yen Cheng, Other Mr. Cheng has received personal compensation for serving as an employee of Bristol Myers Squibb. Mr. Cheng has stock in Bristol Myers Squibb.
Clio A. Rubinos, MD Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qualtrics Inc. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity Pharmaceuticals. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Epilepsy Society . Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Marinus Pharmaceutical. Dr. Rubinos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina .
Olivier Uwishema Mr. Uwishema has nothing to disclose.
Nabeel Nabulsi Nabeel Nabulsi, 21953 has nothing to disclose.
Troy Brown Mr. Brown has nothing to disclose.
Renee Haldenby Renee Haldenby has received personal compensation for serving as an employee of Hoffmann-LaRoche Ltd.
Divya Asher Divya Asher has received personal compensation for serving as an employee of Lundbeck. Divya Asher has received personal compensation for serving as an employee of AbbVie.
Slawomir Opalka Ms. Opalka has received personal compensation for serving as an employee of Transition Technologies PSC . Ms. Opalka has received personal compensation for serving as an employee of Technical University of Lodz. Ms. Opalka has received personal compensation in the range of $500-$4,999 for serving as a Academic teacher with Technical University of Lodz. Ms. Opalka has received personal compensation in the range of $10,000-$49,999 for serving as a PhD candidate with Technical University of Lodz.
Maria Mazurkiewicz-Beldzin Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen, . Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Jennifer Da Jennifer Da has nothing to disclose.
Jean Rama Surya, Other Mr. Surya has nothing to disclose.
Jason Viereck, MD, PhD Dr. Viereck has nothing to disclose.
Kayla Schusterman Ms. Schusterman has nothing to disclose.
Animesh Das, MD Dr. Das has nothing to disclose.
Varun Shandal, MD Dr. Shandal has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for The Killino Firm, P.C..
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Charles Maitland Charles Maitland has nothing to disclose.
James Pham Ho, MD Dr. Ho has nothing to disclose.
Robert Chang Mr. Chang has nothing to disclose.
Paul Maruff, PhD Dr. Maruff has received personal compensation for serving as an employee of Cogstate .
William M. Carroll, MBBS,MD,FRACP,FAAN Dr. Carroll has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Celia Camacho Toledano Mrs. Camacho Toledano has nothing to disclose.
Seo-Young Lee, MD Dr. Lee has nothing to disclose.
Satoko Hori, PhD Prof. Hori has nothing to disclose.
Kennedy Mahdavi, Other Ms. Mahdavi has nothing to disclose.
Martin Keller, PhD Dr. Keller has received personal compensation for serving as an employee of Alexion. Dr. Keller has stock in Alexion, Roche, Novartis, Celgene, Abbvie, Merck, Ionis, Sanofie, Organon, MSD.
Santiago Ortega Gutierrez, MD Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for microvention. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from IschemiaView. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH.
Amer Malik, MD Dr. Malik has nothing to disclose.
Norbert Kovacs The institution of Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for boston Scientific. Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Norbert Kovacs has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Hungarian Scientific Parkinson's Disease Society. The institution of Norbert Kovacs has received research support from Abbott. The institution of Norbert Kovacs has received research support from Hungarian National Research Board.
Sonia Padiglioni Sonia Padiglioni has nothing to disclose.
Sally Dunaway, DPT Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Calvin James Hall, III, PhD Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Virginia Sexual and Domestic Violence Action Alliance.
Lily Lee, PhD Dr. Lee has nothing to disclose.
Evrim Efe Ozcan Mr. Ozcan has nothing to disclose.
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Mohamed A. Ebrahim, MBBS Dr. Ebrahim has nothing to disclose.
Meredith Spindler, MD, FAAN Dr. Spindler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Spindler has received research support from Abbvie. The institution of Dr. Spindler has received research support from Supernus. The institution of Dr. Spindler has received research support from Abbott. The institution of Dr. Spindler has received research support from Takeda. The institution of Dr. Spindler has received research support from Praxis. The institution of Dr. Spindler has received research support from UCB. Dr. Spindler has received publishing royalties from a publication relating to health care.
Brett Loop, MPH Mr. Loop has received personal compensation for serving as an employee of Amgen. Mr. Loop has received personal compensation for serving as an employee of Novartis. Mr. Loop has stock in Vertex Pharmaceuticals . Mr. Loop has stock in Novartis.
Alona Muzikansky Alona Muzikansky has nothing to disclose.
Asad Ikram, MD, MBBS Dr. Ikram has nothing to disclose.
Swathy Chandrashekhar, MD Dr. Chandrashekhar has received publishing royalties from a publication relating to health care.
Elly Lee No disclosure on file
Dmitry Vlodavets Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeutics. Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dmitry Vlodavets has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeutics. Dmitry Vlodavets has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Anmar Razak, MD Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Mark T. Brown, MD Dr. Brown has received personal compensation for serving as an employee of Pfizer Inc. Dr. Brown has received stock or an ownership interest from Pfizer Inc.
Dawn Bates, Other Ms. Bates has nothing to disclose.
Karen C. Holdridge Karen C. Holdridge, 19157 has received personal compensation for serving as an employee of Eli Lilly and Company. Karen C. Holdridge, 19157 has stock in Eli Lilly and Company.
Jeremy Shaw, MD The institution of Dr. Shaw has received research support from LSRS. The institution of Dr. Shaw has received research support from CSRS. The institution of Dr. Shaw has received research support from AO Spine. Dr. Shaw has received intellectual property interests from a discovery or technology relating to health care.
Lydia Cho, Other The institution of Ms. Cho has received research support from Canadian Institutes of Health Research.
Mykaiya Sumling Ms. Sumling has received personal compensation for serving as an employee of Georgetown Medstar.
Alicia Stowe, Other Mrs. Stowe has nothing to disclose.
Carmen Morinelli Miss Morinelli has nothing to disclose.
Bruno Cenni Mr. Cenni has received personal compensation for serving as an employee of Novartis.
Piers Klein Mr. Klein has nothing to disclose.
Eugenio Mercuri Eugenio Mercuri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta, Santhera, PTC, Pfizer, Roche, Biogen, Avexis Novartis, Scholar Rock, Cytokinetics. Eugenio Mercuri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sarepta, Santhera, PTC, Pfizer, Roche, Biogen, Avexis Novartis. The institution of Eugenio Mercuri has received research support from biogen.
Daniel Wang Forsman, MD Dr. Forsman has stock in Eli Lilly and Co. Dr. Forsman has stock in Moderna Inc.
Mari Paz Serrano Regal, PhD Dr. Serrano Regal has nothing to disclose.
Lars Viktrup Lars Viktrup has received personal compensation for serving as an employee of Lilly. Lars Viktrup has stock in Lilly.
Daniel Maslyar, MD Dr. Maslyar has received personal compensation for serving as an employee of Alector. Dr. Maslyar has stock in Alector.
Divya R. Ganugapati Miss Ganugapati has nothing to disclose.
Henry J. Kaminski, MD, FAAN The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Kaminski has stock in ARC Biotechnology. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Sharon Thomson, Other Miss Thomson has nothing to disclose.
Angad Chhabra Mr. Chhabra has nothing to disclose.
Todd Mulderink No disclosure on file
Nora Hernandez Nora Hernandez has nothing to disclose.
Sergio Saldivar, MD Dr. Saldivar has nothing to disclose.
Barbara Plitnick, RN Ms. Plitnick has nothing to disclose.
Sophie Barlow Miss Barlow has nothing to disclose.
Emrah Aras, MD Dr. Aras has received personal compensation for serving as an employee of Alexion Pharmaceuticals Inc.
Anand Viswanathan, MD Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Collin Culbertson, MD Dr. Culbertson has nothing to disclose.
Elan D. Louis, MD, MS, FAAN Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. The institution of Dr. Louis has received research support from National Institutes of Health.
Nikash Shankar, MD Mr. Shankar has received personal compensation for serving as an employee of Medstar Georgetown.
David Brodie-Mends, MD Dr. Brodie-Mends has nothing to disclose.
Chhitij Tiwari Mr. Tiwari has nothing to disclose.
Michael Chan Michael Chan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biomimetix. Michael Chan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Monteris.
Thao Dinh, RN Miss Dinh has nothing to disclose.
Ajay Garg Ajay Garg has nothing to disclose.
Jamie Conklin, Other Mrs. Conklin has nothing to disclose.
Sevim Erdem-Ozdamar, MD No disclosure on file
Sergio Adrian Becerra Mr. Becerra has nothing to disclose.
Kristy Rose Kristy Rose has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Kristy Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Kristy Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Kristy Rose has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Jesse Thon, MD An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Carmen Martin Carmen Martin has received personal compensation for serving as an employee of Roche Products Ltd. Carmen Martin has received stock or an ownership interest from F. Hoffmann-La Roche Ltd.
Douglas C. Wolf No disclosure on file
Antreas Charidimou, MD, PhD. MSc Dr. Charidimou has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Imperative Care. Dr. Charidimou has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Journal of Neurological Sciences.
Ludo J. Vanopdenbosch, MD, FAAN Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F Hoffmann La Roche. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Vanopdenbosch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Fahham Asghar, MD Mr. Asghar has nothing to disclose.
Kiersten Mangold Miss Mangold has nothing to disclose.
Sheldon E. Jordan, MD Dr. Jordan has stock in Synaptec Network.
Nadia McMillan, MD, PhD Dr. McMillan has nothing to disclose.
Matthew Mauck, MD,PhD Dr. Mauck has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for North Carolina Industrial Commission. The institution of Dr. Mauck has received research support from NIH.
Edward Joseph Weldon, IV, Other Mr. Weldon has nothing to disclose.
Hyeyoung Seol, MD Dr. Seol has nothing to disclose.
Maria Cristina Ortega, PhD Dr. Ortega has nothing to disclose.
Francisco J. Quintana, PhD Dr. Quintana has nothing to disclose.
Hiba Naveed, MD Ms. Naveed has nothing to disclose.
Duaa Jabari, MD Dr. Jabari has nothing to disclose.
Christina Kourkoulis Christina Kourkoulis has nothing to disclose.
Davana Ramaswamy, MD Dr. Ramaswamy has nothing to disclose.
Mark J. Kelly, MBBS The institution of Dr. Kelly has received research support from The Health Research Board / Wellcome Trust.
Timothé Langlois-Thérien, Jr., MD Mr. Langlois-Thérien has nothing to disclose.
Muhammad Waseem Anjum, MD Dr. Anjum has nothing to disclose.
Jonathan Stokes Jonathan Stokes has received personal compensation for serving as an employee of AbbVie. Jonathan Stokes has received stock or an ownership interest from AbbVie.
Guillaume Joerger, PhD Dr. Joerger has nothing to disclose.
Paige Buddenhagen Paige Buddenhagen has nothing to disclose.
Kathryn Rosenbluth Kathryn Rosenbluth has received personal compensation for serving as an employee of Cala Health. Kathryn Rosenbluth has received stock or an ownership interest from Cala Health.
Claudia A. Chiriboga, MD, FAAN Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Chiriboga has received research support from Roche. The institution of Dr. Chiriboga has received research support from Avexis/Novartis. The institution of Dr. Chiriboga has received research support from Biogen. The institution of Dr. Chiriboga has received research support from NIH. The institution of Dr. Chiriboga has received research support from Biohaven. The institution of Dr. Chiriboga has received research support from Genentec. Dr. Chiriboga has received publishing royalties from a publication relating to health care.
Lauryn Hemminger Dr. Hemminger has nothing to disclose.
Wenwen Zhang, MD, PhD Dr. Zhang has nothing to disclose.
Abhigyan Datta, MBBS Dr. Datta has nothing to disclose.
Chancen Law, Other Mr. Law has nothing to disclose.
Andrea Sujung Yoo, MD Dr. Yoo has received research support from Edmond J Safra Foundation.
David Hallan, MD Dr. Hallan has nothing to disclose.
Benedetta Nacmias Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Richard A L Macdonell, MD, FAAN Dr. Macdonell has nothing to disclose.
Regine Buffels, MD Dr. Buffels has nothing to disclose.
Jin Nakahara, MD, PhD Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from EA Pharma. The institution of Prof. Nakahara has received research support from JB. The institution of Prof. Nakahara has received research support from Eisai. The institution of Prof. Nakahara has received research support from Shionogi. The institution of Prof. Nakahara has received research support from Boehringer Ingelheim. The institution of Prof. Nakahara has received research support from Kyowa Kirin. The institution of Prof. Nakahara has received research support from Sumitomo Pharma. The institution of Prof. Nakahara has received research support from Otsuka. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Teijin. The institution of Prof. Nakahara has received research support from Mitsubishi-Tanabe.
Todd J. Schwedt, MD, FAAN Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Science. Dr. Schwedt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Schwedt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Linpharma. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Schwedt has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Schwedt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Schwedt has stock in Aural Analytics. Dr. Schwedt has stock in Nocira. The institution of Dr. Schwedt has received research support from Amgen. The institution of Dr. Schwedt has received research support from National Institutes of Health. The institution of Dr. Schwedt has received research support from United States Department of Defense. The institution of Dr. Schwedt has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Schwedt has received research support from SPARK Neuro. The institution of Dr. Schwedt has received research support from Henry Jackson Foundation. Dr. Schwedt has received intellectual property interests from a discovery or technology relating to health care. Dr. Schwedt has received publishing royalties from a publication relating to health care.
Victoria Venkatraman Ms. Venkatraman has nothing to disclose.
Bilal Rizvi Mr. Rizvi has received research support from University of Calgary .
Eamonn O'Brien, Other Mr. O'Brien has received personal compensation for serving as an employee of Novartis. Mr. O'Brien has stock in Novartis.
Julie Blant Ms. Blant has nothing to disclose.
May Han, MD Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Lawrence Scott Blaszkowsky, MD Dr. Blaszkowsky has nothing to disclose.
Patrick Brown, MD Dr. Brown has nothing to disclose.
Anjail Sharrief, MD The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to AAN interests or activities.
Mireia Forner, Other Mrs. Forner has received personal compensation for serving as an employee of Sanofi.
Sami Alkasab, MD No disclosure on file
Vishva Natarajan Mr. Natarajan has received personal compensation for serving as an employee of Pfizer. Mr. Natarajan has stock in Apple. Mr. Natarajan has stock in Tesla. Mr. Natarajan has stock in Microsoft. Mr. Natarajan has stock in Mind Medicine. Mr. Natarajan has received research support from Georgia Institute of Technology.
Darko Ernesto Quispe Orozco, MD Dr. Quispe Orozco has nothing to disclose.
Charles Spinale, Other Mr. Spinale has received personal compensation for serving as an employee of The Harris Poll.
Hari Miskin, Other Mr. Miskin has received personal compensation for serving as an employee of TG Therapeutics. Mr. Miskin has stock in TG Therapeutics .
Likhita Shaik, MBBS Dr. Shaik has nothing to disclose.
Ashkan Vaziri, PhD Dr. Vaziri has received personal compensation for serving as an employee of Biosensics.
Kodwo Oduro Nkromah, MD Dr. Nkromah has nothing to disclose.
Janbernd Kirschner Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genethon. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Italfarmaco. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. The institution of Janbernd Kirschner has received research support from Roche. The institution of Janbernd Kirschner has received research support from Biogen. The institution of Janbernd Kirschner has received research support from Novartis.
Juri Balestrini, MD Dr. Balestrini has nothing to disclose.
Richa Tripathi, MD Dr. Tripathi has nothing to disclose.
Felix E. Fernandez-Penny, Other Mr. Fernandez-Penny has nothing to disclose.
AnnKatrin Petersen No disclosure on file
Poorvi Tangri, Other Ms. Tangri has nothing to disclose.
Justin Singer Justin Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker. Justin Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Justin Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceronovus. Justin Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Nico. The institution of Justin Singer has received research support from Stryker Grant.
Donald A. Smith, MD Dr. Smith has nothing to disclose.
Assunta Ingannato Dr. Ingannato has nothing to disclose.
Amanda Walker Miss Walker has nothing to disclose.
Connie C. Marras, MD Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Japanese Tobacco. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurinia Pharmaceuticals. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Oxford Health Policy Forum. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Peervoice. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bristows .
David Orlikowski, MD No disclosure on file
Darryl C. De Vivo, MD, FAAN Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
R. Davis Moore, PhD Dr. Moore has nothing to disclose.
Kathryn Giles Kathryn Giles has stock in Synderdisc. The institution of Kathryn Giles has received research support from Biogen.
Filippo Emiliani, MD Dr. Emiliani has nothing to disclose.
Felix Leejia Yeh, PhD Dr. Yeh has received stock or an ownership interest from Alector. Dr. Yeh has received stock or an ownership interest from Genentech. Dr. Yeh has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist with Genentech. Dr. Yeh has received personal compensation in the range of $100,000-$499,999 for serving as a Head of Biomarkers with Alector.
Ryo Takemura, PhD Dr. Takemura has nothing to disclose.
Manuel Requena, MD,PhD Dr. Requena has nothing to disclose.
Juan Pablo Castello, MD No disclosure on file
Markus Kraemer Markus Kraemer has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Chugai.
Sean Goretzke, MD Dr. Goretzke has nothing to disclose.
Leigh Macintyre Ms. Macintyre has nothing to disclose.
Maya Pandit, MPH Ms. Pandit has nothing to disclose.
Laura Palfreeman Laura Palfreeman has received personal compensation for serving as an employee of Roche.
Paola Testini, MD Dr. Testini has nothing to disclose.
Jennifer L. Reardon Jennifer L. Reardon has received personal compensation for serving as an employee of Bristol Myers Squibb.
Seiya Ohtani Mr. Ohtani has nothing to disclose.
Guenther Deuschl, MD, FAAN Dr. Deuschl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Deuschl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Cavion Functional Neuromodulation. The institution of Dr. Deuschl has received research support from Medtronic. Dr. Deuschl has received publishing royalties from a publication relating to health care.
Akashleena Mallick, MD, MBBS Dr. Mallick has nothing to disclose.
Constantine Farmakidis, MD, FAAN Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Jiajia Zhang, PhD Dr. Zhang has nothing to disclose.
Khaled Gharaibeh, MD Dr. Gharaibeh has nothing to disclose.
Muna El-Khairi Muna El-Khairi has received personal compensation for serving as an employee of Roche Products Limited.
Hanhui Fu No disclosure on file
Nicola De Rossi Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Antje Tockhorn-Heidenreich Antje Tockhorn-Heidenreich has received personal compensation for serving as an employee of Eli Lilly and Company. An immediate family member of Antje Tockhorn-Heidenreich has received personal compensation for serving as an employee of Evidera. Antje Tockhorn-Heidenreich has received stock or an ownership interest from Eli Lilly and Company . An immediate family member of Antje Tockhorn-Heidenreich has received stock or an ownership interest from PPD.
Hooman Kamel, MD Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Ajay Madhavan Ajay Madhavan has nothing to disclose.
Anthony Thompson, Other Mr. Thompson has nothing to disclose.
Alexander Wagner, MD Dr. Wagner has nothing to disclose.
Laura Airas, MD, PhD The institution of Dr. Airas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. The institution of Dr. Airas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Ellen Lathi, MD Dr. Lathi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Shashvat Desai, MD Dr. Desai has nothing to disclose.
Kilian Hett, PhD Dr. Hett has nothing to disclose.
EzzEldin Hesham Abouelatta Mr. Abouelatta has nothing to disclose.
Joseph Michael Palumbo, MD Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has stock in BioVie. An immediate family member of Dr. Palumbo has stock in Merck Research Laboratories. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
Rebecca Siobhan-Ivy Cox, Other Ms. Cox has nothing to disclose.
Michal Openchowski, Other Mr. Openchowski has received personal compensation for serving as an employee of Roche. Mr. Openchowski has stock in Roche.
Kore K. Liow, MD, FACP The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Ajaz Sheikh, MD Dr. Sheikh has nothing to disclose.
John Pham Mr. Pham has nothing to disclose.
Emma Chatterton Miss Chatterton has nothing to disclose.
Dominique Popescu, PhD Dr. Popescu has nothing to disclose.
Kassie Lyn McCullagh, MD Dr. McCullagh has nothing to disclose.
Pascal Laforet No disclosure on file
Ibrahim Abbass, PhD Dr. Abbass has received personal compensation for serving as an employee of Genentech.
Andrew Galazka Andrew Galazka has received personal compensation for serving as an employee of Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany.
Cynthia Morris No disclosure on file
Donald Crammond Donald Crammond has nothing to disclose.
Emma Touré Cuq, Other Mrs. Touré Cuq has received personal compensation for serving as an employee of Ad Scientiam .
Grey Skelton Mr. Skelton has received personal compensation for serving as an employee of AthenaHealth.
Bernardo Cacho Diaz, MD Dr. Cacho Diaz has nothing to disclose.
Dawn Meyer Dawn Meyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chiesi. Dawn Meyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Portola.
Aditya S. Pandey, MD Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NIH and SVIN- Journal. Dr. Pandey has stock in FlexDex. Dr. Pandey has stock in NextGen. The institution of Dr. Pandey has received research support from NIH. The institution of Dr. Pandey has received research support from Focused ultrasound foundation. Dr. Pandey has received intellectual property interests from a discovery or technology relating to health care.
Stavros Matsoukas, MD Dr. Matsoukas has nothing to disclose.
Anish Patel Anish Patel has nothing to disclose.
Zachary Hodosevich, MD Dr. Hodosevich has nothing to disclose.
Aya A. Ouf, MBBS Dr. Ouf has nothing to disclose.
Odile Boespflug-Tanguy Odile Boespflug-Tanguy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Minoryx. Odile Boespflug-Tanguy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inventiva. Odile Boespflug-Tanguy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BLUEBIRD.
Mikel Martinez, MD No disclosure on file
Sara Esmaeili, MD Dr. Esmaeili has nothing to disclose.
Martin Christian Strahm, PhD Dr. Strahm has received personal compensation for serving as an employee of F. Hoffmann-La Roche.
Ziqi Zhou, III, Other Ms. Zhou has nothing to disclose.
Guangsong Han Mr. Han has nothing to disclose.
Nicole LaMarca Ms. LaMarca has received personal compensation for serving as an employee of Novartis Gene Therapies.
Matthew Anderson, DO Dr. Anderson has nothing to disclose.
Neil Nguyen, Other Mr. Nguyen has nothing to disclose.
Cheongeun Oh, PhD Prof. Oh has nothing to disclose.
Owen Thomas, Other Mr. Thomas has nothing to disclose.
Ana Julia Moreira, PhD Dr. Moreira has received personal compensation for serving as an employee of Ad Scientiam.
Bijan Pourat, MD Dr. POURAT has nothing to disclose.
Richard Shell Richard Shell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis. Richard Shell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Robert T. Naismith, MD, FAAN Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Sravanthi Koduri No disclosure on file
Mudassir Farooqui, MD Dr. Farooqui has nothing to disclose.
James K. Sheffield, MD Dr. Sheffield has received personal compensation for serving as an employee of BMS.
Lina Yang Dr. Yang has nothing to disclose.
Mouhammad A. Jumaa, MD Dr. Jumaa has nothing to disclose.
Andres Dajles Andres Dajles has nothing to disclose.
Krupa Shah Pandey, MD Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pandey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Pandey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Pandey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen . Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech . Dr. Pandey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon Therapeutics . The institution of Dr. Pandey has received research support from NIH. The institution of Dr. Pandey has received research support from CMSC.
Julia Wang, MD Mrs. Wang has nothing to disclose.
Juanjuan Wu, Other Dr. Wu has nothing to disclose.
Rana Samir Rouby Ahmed, MBBS Dr. Ahmed has nothing to disclose.
Lena *USE ID 377161 Loesslein, PhD Mrs. Loesslein has nothing to disclose.
Valentina Moschini, Neuropsychologist Miss Moschini has nothing to disclose.
April DeStefano, MD Miss DeStefano has nothing to disclose.
Paula K. Ogrocki Paula K. Ogrocki has nothing to disclose.
Philip Rosenbaum Mr. Rosenbaum has received research support from Region IV Training Center.
Julianne Lee, Other Ms. Lee has nothing to disclose.
Abhishek Datta No disclosure on file
Ronda Lun, MD Dr. Lun has nothing to disclose.
Omar Dabbous, MD Dr. Dabbous has received personal compensation for serving as an employee of NOVARTIS GENE THERAPIES, INC.. Dr. Dabbous has stock in NOVARTIS GENE THERAPIES, INC.
Ana M. Gimenez-Arnau, MD,PhD Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uriach Pharma. Prof. Gimenez-Arnau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAnofi Regeneron . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thermo Fisher . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CElldex . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Uriach Pharma. Prof. Gimenez-Arnau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Prof. Gimenez-Arnau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi . Prof. Gimenez-Arnau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Menarini . The institution of Prof. Gimenez-Arnau has received research support from Instituto CArlos III. The institution of Prof. Gimenez-Arnau has received research support from URIACH . The institution of Prof. Gimenez-Arnau has received research support from NOVARTIS . Prof. Gimenez-Arnau has received publishing royalties from a publication relating to health care.
Jonathan Bryant, MD Dr. Bryant has nothing to disclose.
Guillaume Nicolas, MD,PhD Prof. NICOLAS has nothing to disclose.
Sara Eichau Madueno Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Sara Eichau Madueno has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Sara Eichau Madueno has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Sara Eichau Madueno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck.
Nils Petersen, MD Dr. Petersen has received research support from NIH.
Sibel Goksen, PhD Mrs. Goksen has nothing to disclose.
Leticia Tornes, MD, FAAN Dr. Tornes has nothing to disclose.
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Michael Malek-Ahmadi Michael Malek-Ahmadi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health.
Simonetta Gerevini Simonetta Gerevini has nothing to disclose.
Sophia Keins Ms. Keins has nothing to disclose.
Sandro Sorbi Sandro Sorbi has nothing to disclose.
Yingying Liu Yingying Liu has received personal compensation for serving as an employee of Biogen. Yingying Liu has received stock or an ownership interest from Biogen.
Jacqueline Pesa, PhD Dr. Pesa has received personal compensation for serving as an employee of Janssen. Dr. Pesa has stock in J&J.
Ayush Prasad Mr. Prasad has nothing to disclose.
Silvia Bagnoli, PhD Dr. Bagnoli has nothing to disclose.
Jean K. Mah, MD, FRCPC, FAAN Dr. Mah has nothing to disclose.
Roger Cady, MD Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Xiaotong *Use 344485 Jiang Xiaotong Jiang has nothing to disclose.
Dusica Babovic-Vuksanovic, MD Dr. Babovic-Vuksanovic has received personal compensation for serving as an employee of AstraZeneka. Dr. Babovic-Vuksanovic has received personal compensation for serving as an employee of Alexion. Dr. Babovic-Vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Babovic-Vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Babovic-Vuksanovic has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca . Dr. Babovic-Vuksanovic has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Loeb&Loeb. The institution of Dr. Babovic-Vuksanovic has received research support from DOD. Dr. Babovic-Vuksanovic has received publishing royalties from a publication relating to health care.
Sumit Verma, MD Dr. Verma has nothing to disclose.
Elizabeth Padron, MD Dr. Padron has nothing to disclose.
Oksana Mokliatchouk Oksana Mokliatchouk has received personal compensation for serving as an employee of Biogen. Oksana Mokliatchouk has received stock or an ownership interest from Biogen.
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Rohit Bhatia, MBBS, MD, DM Dr. Bhatia has nothing to disclose.
Rikki Mangrum, Other An immediate family member of Ms. Mangrum has received personal compensation for serving as an employee of GSK. Ms. Mangrum has received personal compensation for serving as an employee of Vector Psychometric Group.
Raghu Mulukutla, Other Mr. Mulukutla has received personal compensation for serving as an employee of BioSensics LLC.
Brian Dewar No disclosure on file
Yiyun Huang An immediate family member of Yiyun Huang, 8202 has stock in Pfiy. An immediate family member of Yiyun Huang, 8202 has stock in Johnson and Johnson . Yiyun Huang, 8202 has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Gunes Esendagli Gunes Esendagli has nothing to disclose.
Vasileios-Arsenios Lioutas, MD Dr. Lioutas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Qmetis. Dr. Lioutas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mindray. The institution of Dr. Lioutas has received research support from NIH. The institution of Dr. Lioutas has received research support from Alzheimer's Association.
Hana Florian Hana Florian has received personal compensation for serving as an employee of AbbVie. Hana Florian has stock in AbbVie.
Ashley Becker, MD Dr. Becker has nothing to disclose.
Susana Quijano-Roy, MD,PhD Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis GT. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAnofi Genzyme. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AVEXIS. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS GT. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis GT. Prof. Quijano-Roy has received publishing royalties from a publication relating to health care.
Jeffrey A. Loeb, MD, PhD Dr. Loeb has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Sturge Weber Foundation. Dr. Loeb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various Law firms. The institution of Dr. Loeb has received research support from Patrick Grange Memorial Foundation. Dr. Loeb has received intellectual property interests from a discovery or technology relating to health care.
Mary Carter Denny, MD Dr. Denny has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Laboratory. The institution of Dr. Denny has received research support from NIDDILIR. Dr. Denny has received publishing royalties from a publication relating to health care.
Jamie Pardini Jamie Pardini has nothing to disclose.
Cara Cawley, DO Dr. Cawley has nothing to disclose.
Debarati Bhanja, MD Ms. Bhanja has nothing to disclose.
Dirk Fischer The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann La Roche AG. The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann La Roche AG.
Jean C. Ouallet Jean C. Ouallet has nothing to disclose.
Jenny Peih-Chir Tsai, MD Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Q'Apel. Dr. Tsai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. Dr. Tsai has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of NeuroInterventional Surgery.
Katelyn R. Keyloun, Other Dr. Keyloun has received personal compensation for serving as an employee of AbbVie. Dr. Keyloun has stock in AbbVie.
Ashley Nelson, DO Dr. Nelson has nothing to disclose.
Joon Lee, MD Dr. Lee has nothing to disclose.
Deepti Vibha, MD Dr. Vibha has nothing to disclose.
Troy Herter, PhD The institution of Dr. Herter has received research support from Woodcock Institute. The institution of Dr. Herter has received research support from National Institutes of Health. The institution of Dr. Herter has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Herter has received research support from Centers for Disease Control and Prevention.
Alan P. Pan Mr. Pan has nothing to disclose.
Caitlin Moran, MD Dr. Moran has nothing to disclose.
Katherine Melonakos Anetakis, MD Dr. Anetakis has nothing to disclose.
Tracy K. Nishida, PhD Dr. Nishida has received personal compensation for serving as an employee of VPG.
Katherine March, Other Dr. March has nothing to disclose.
Pamela Wolters, PhD Dr. Wolters has stock in Bristol-Myers-Squibb. The institution of Dr. Wolters has received research support from Neurofibromatosis Therapeutic Acceleration Program.
Preet M. Varade, MD Dr. Varade has nothing to disclose.
Edmar Zanoteli Edmar Zanoteli has nothing to disclose.
Iulian Alecu, MD Dr. Alecu has stock in Novartis.
Lesa Mehl Lesa Mehl has received personal compensation for serving as an employee of AveXis / Novartis Gene Therapies / Novartis Institutes for Biomedical Research, Inc. Lesa Mehl has stock in Novartis.
Richard Siegel, MD,PhD Dr. Siegel has received personal compensation for serving as an employee of Novartis. Dr. Siegel has stock in Novartis.
Sonu Sahni, MD Dr. Sahni has nothing to disclose.
Svjetlana Miocinovic, MD, PhD Dr. Miocinovic has nothing to disclose.
Joshua Chung Mr. Chung has nothing to disclose.
Olivia Kingsford, DO Dr. Kingsford has nothing to disclose.
Jonathan William Perry Kuziek Mr. Kuziek has nothing to disclose.
Amy Perrin Ross, RN,MSN,CNRN Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving as a Consultant for Alexion. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Ms. Perrin Ross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Rebecca Merrill Ms. Merrill has nothing to disclose.
Shawn Alter, PhD Dr. Alter has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Alter has stock in Axsome Therapeutics.
Zachariah Thomas Zachariah Thomas has received personal compensation for serving as an employee of Axsome. Zachariah Thomas has stock in Axsome .
Thomas Doerner, MD Prof. Doerner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Prof. Doerner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/GNE. Prof. Doerner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Ramy Abdelnaby, MD,PhD Dr. Abdelnaby has nothing to disclose.
Zia Ulhaq Chaudhry, MD,PhD Dr. Chaudhry has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Chaudhry has received personal compensation for serving as an employee of Takeda Pharmaceuticals.
Katrina Cardiff, PT Mrs. Cardiff has nothing to disclose.
Axel Nolting Axel Nolting has received personal compensation for serving as an employee of Merck Healthcare KGaA. Axel Nolting has received stock or an ownership interest from Merck Healthcare KGaA.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Imene Maallem, Jr., MD Ms. Maallem has nothing to disclose.
Ruta Deshpande Ruta Deshpande has nothing to disclose.
Christopher Giza, MD, FAAN Dr. Giza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highmark Interactive. Dr. Giza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceutical. Dr. Giza has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lewitt, Hackman, Shapiro, Marshall & Harlan. Dr. Giza has received stock or an ownership interest from Highmark Interactive. The institution of Dr. Giza has received research support from NCAA. The institution of Dr. Giza has received research support from US Department of Defense. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care.
Annette Okai, MD, FAAN Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD SERONO . Dr. Okai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme .
Riya Bhavsar, MD Dr. Bhavsar has nothing to disclose.
Devin Simon, MD Dr. Simon has nothing to disclose.
Imari Genias Miss Genias has nothing to disclose.
Michael E. Reznik, MD Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Sopiko Jimsheleishvili, MD Ms. Jimsheleishvili has nothing to disclose.
Mohammad Abu-Rub, MD Dr. Abu-Rub has nothing to disclose.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Gabriela Figueiredo Pucci, MD Dr. Figueiredo Pucci has nothing to disclose.
Tefani Perera, MD Dr. Perera has nothing to disclose.
Adrian Laxton Adrian Laxton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Adrian Laxton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Monteris .
Kathryn J. Swoboda, MD Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen.
Joey C. Boiser, MD Dr. Boiser has received personal compensation for serving as an employee of AbbVie. Dr. Boiser has stock in AbbVie.
Prem Kandiah, MD Dr. Kandiah has nothing to disclose.
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla.
Tristan Anthony Ponzo Mr. Ponzo has nothing to disclose.
Angelina Woof, PT Ms. Woof has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ATOM. Ms. Woof has received personal compensation in the range of $50,000-$99,999 for serving as a Leader of Physiotherapy with BC Centre for Ability.
Daniel Weintraub Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Joseph Eric Malone, MD Dr. Malone has nothing to disclose.
Gordon Sussman, MD Dr. Sussman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Sussman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sussman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Randall Edgell, MD Dr. Edgell has nothing to disclose.
Paul Votto, Other Mr. Votto has received personal compensation for serving as an employee of Yale university .
Hua Long Hua Long has received personal compensation for serving as an employee of Alector. Hua Long has received stock or an ownership interest from Alector. Hua Long has received intellectual property interests from a discovery or technology relating to health care.
Rachel J. Saunders-Pullman, MD The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Jeffrey Alan Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Brian Werneburg Mr. Werneburg has received personal compensation for serving as an employee of Alexion.
Isabelle Desguerre, MD Prof. Desguerre has nothing to disclose.
Shiri Wallach Shiri Wallach has received personal compensation for serving as an employee of Novartis . Shiri Wallach has stock in Novartis .
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scholar Rock. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Malgorzata Miller, MD Dr. Miller has nothing to disclose.
Yessar M. Hussain, MD The institution of Dr. Hussain has received research support from Alnylam Pharma.
Kevin Alexander Soltany Mr. Soltany has received personal compensation for serving as an employee of Alliance for Health Policy. Mr. Soltany has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Affairs.
Mahjabeen Ahmed Khan, MBBS Dr. Ahmed Khan has nothing to disclose.
Ka Loong Kelvin Au, MD Dr. Au has nothing to disclose.
Lovingly Park, PhD Dr. Park has received personal compensation for serving as an employee of Alector. Dr. Park has received personal compensation for serving as an employee of Supernus Pharmaceuticals. Dr. Park has stock in Alector.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Elisabeth Rindner Ms. Rindner has nothing to disclose.
Andrew Joseph Bouley, MD Dr. Bouley has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Bouley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bouley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Bouley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Bouley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bouley has received research support from Novartis.
Colin McKnight, MD An immediate family member of Dr. McKnight has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Deciphera. The institution of Dr. McKnight has received research support from RSNA.
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Sandra P. Reyna, MD Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies.
Andrea C. Wasilewski, MD Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure.
Stephen B. Tatter, MD The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
Omar Jawdat, MD Dr. Jawdat has nothing to disclose.
Chase Michael Irwin, Other Mr. Irwin has nothing to disclose.
Brett Steven Gunn Mr. Gunn has nothing to disclose.
Howard Fillit, MD No disclosure on file
Jorge Rodriguez-Fernandez, MD Dr. Rodriguez-Fernandez has nothing to disclose.
Sylvia R. Delgado, MD, FAAN The institution of Dr. Delgado has received research support from Novartis. The institution of Dr. Delgado has received research support from EMD Serono.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Carolina Barnett Tapia, MD Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $0-$499 for serving as a Consultant for Sanofi. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Lauren Doyle Strauss, DO Dr. Strauss has a non-compensated relationship as a Secretary with Southern Headache Society that is relevant to AAN interests or activities.
Karen Kadner Karen Kadner has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd.
Neha Prakash, MD The institution of Dr. Prakash has received research support from UCB Biosciences Inc.. The institution of Dr. Prakash has received research support from Parkinson Foundation.
Leticia Calahorra, PhD,MD Dr. Calahorra has nothing to disclose.
Kamal Benguerba Kamal Benguerba has received personal compensation for serving as an employee of Novartis Gene Therapies. Kamal Benguerba has stock in Novartis Gene Therapies.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Angela Dodman Angela Dodman has received personal compensation for serving as an employee of F. Hoffman-La Roche Ltd.
Xiao M. Androulakis, MD The institution of Dr. Androulakis has received research support from VA rehabilitation research .
Nirav Vora, MD No disclosure on file
Dhira Khosla, DO Dr. Khosla has received personal compensation for serving as an employee of Cala Health. Dr. Khosla has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cala Health.
Liana Hennum, PT,Other Mrs. Hennum has received personal compensation for serving as an employee of Cala Health.
Jarrod Eisma Mr. Eisma has nothing to disclose.
Jennifer García Arocha Mrs. Arocha has nothing to disclose.
Leigh Elkins Charvet, PhD Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Kathy Steinberg Ms. Steinberg has received personal compensation for serving as an employee of The Harris Poll.
Herriot Tabuteau, MD Dr. Tabuteau has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Tabuteau has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axsome Therapeutics. Dr. Tabuteau has received stock or an ownership interest from Axsome Therapeutics. Dr. Tabuteau has received intellectual property interests from a discovery or technology relating to health care.
Shaainthabie Karthigesu, PT Miss Karthigesu has nothing to disclose.
Mariana Gross Figueiro, PhD The institution of Dr. Figueiro has received research support from NIH. The institution of Dr. Figueiro has received research support from EU. The institution of Dr. Figueiro has received research support from McClung Foundation.
Ana Nakamura Ms. Nakamura has nothing to disclose.
Thy Nguyen, MD Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Vijayakumar Javalkar, MD, FAAN Dr. Javalkar has nothing to disclose.
Bryan Collier, DO Dr. Collier has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm.
Roman Willi, PhD Dr. Willi has received personal compensation for serving as an employee of Novartis Pharma. Dr. Willi has received stock or an ownership interest from Novartis.
Andrea Klein Andrea Klein has nothing to disclose.
Imogen Carruthers, Other Miss Carruthers has received personal compensation for serving as an employee of Roche. Miss Carruthers has received stock or an ownership interest from Roche.
Abhishek Pathak, MD, MBBS, DM Dr. Pathak has nothing to disclose.
Anqi Luo, MD Dr. Luo has nothing to disclose.
Oleg Tcheremissine, MD The institution of Prof. Tcheremissine has received research support from Eli Lilly . The institution of Prof. Tcheremissine has received research support from Genentech/Roche. The institution of Prof. Tcheremissine has received research support from Janssen . The institution of Prof. Tcheremissine has received research support from Athira Pharma.
Anastasia Zekeridou, MD, PhD The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care.
Clarissa Gorin, Other Dr. Gorin has received personal compensation for serving as an employee of Ad Scientiam.
Adina Wise, MD Dr. Wise has nothing to disclose.
Bethany Williams, PhD Dr. Williams has received research support from UTHealth at Houston.
Anthony Bannon, PhD Dr. Bannon has received personal compensation for serving as an employee of AbbVie. Dr. Bannon has stock in AbbVie.
Emma Marie Parolisi, MD Ms. Parolisi has nothing to disclose.
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Christopher Hess, MD The institution of Dr. Hess has received research support from Parkinson's Foundation.
Judea Wiggins, MD Dr. Wiggins has nothing to disclose.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Antonio Pato Antonio Pato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Antonio Pato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Antonio Pato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Antonio Pato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Rui Sun, MD,PhD Dr. Sun has nothing to disclose.
Oscar Bortolami, PhD Dr. Bortolami has received personal compensation for serving as an employee of Roche. Dr. Bortolami has received personal compensation in the range of $500-$4,999 for serving as a Statistical Reviewer with Emergency Medicine Journal.
Kim Griffin, MD Dr. Griffin has nothing to disclose.
Raphael Bernard-Valnet, MD, PhD Dr. Bernard-Valnet has nothing to disclose.
Annika Anderson, Other Miss Anderson has nothing to disclose.
Shadi Yaghi, MD Dr. Yaghi has nothing to disclose.
Jennifer Lyons Dr. Lyons has received personal compensation for serving as an employee of Biogen. Dr. Lyons has received stock or an ownership interest from Biogen.
Ryan Nakamura Mr. Nakamura has received personal compensation for serving as an employee of Hawaii Health & Harm Reduction Center.
Abby Lindsay Miss Lindsay has nothing to disclose.
Richard *use 387420 Batrla, MD No disclosure on file
Connor Goo Mr. Goo has nothing to disclose.
Hanane Akbarnejad, Other Ms. Akbarnejad has nothing to disclose.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Rivka Zians Ms. Zians has nothing to disclose.
Kodai Kume, MD,PhD Dr. Kume has nothing to disclose.
Dheeraj Raju, PhD Dr. Raju has nothing to disclose.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Carrie R. Houts Carrie R. Houts has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.
Jennifer Cheng, MD Jennifer Cheng, MD has nothing to disclose.
Aleem Mohamed Mr. Mohamed has nothing to disclose.
Shau Yu Lynch Shau Yu Lynch has received personal compensation for serving as an employee of AbbVie. Shau Yu Lynch has received personal compensation for serving as an employee of Eisai. Shau Yu Lynch has stock in AbbVie.
Sundarshini Ramanathan No disclosure on file
Gregor Gibson Mr. Gibson has received personal compensation for serving as an employee of Adelphi Real World.
Vamsi Krishna Gorijala, MBBS Dr. Gorijala has nothing to disclose.
David Rubin, MD Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alimentiv, Inc. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Altrubio. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arena Pharmaceuticals. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aslan Pharmaceuticals. Dr. Rubin has received personal compensation in the range of $0-$499 for serving as a Consultant for Athos Therapeutics. Dr. Rubin has received personal compensation in the range of $0-$499 for serving as a Consultant for Bellatrix Pharmaceuticals. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim, Ltd. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol-Myers Squibb. Dr. Rubin has received personal compensation in the range of $0-$499 for serving as a Consultant for Celgene Corp/Syneos. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ClostraBio. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Connect BioPharma. Dr. Rubin has received personal compensation in the range of $0-$499 for serving as a Consultant for Datos Health, Ltd. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1. Dr. Rubin has received personal compensation in the range of $0-$499 for serving as a Consultant for Evinature, Ltd. Dr. Rubin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Rubin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gilead Sciences. Dr. Rubin has received personal compensation in the range of $0-$499 for serving as a Consultant for Ironwood Pharmaceuticals. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Iterative Scopes. Dr. Rubin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kaleido Biosciences. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly, Eli & Co. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Prometheus Biosciences. Dr. Rubin has received personal compensation in the range of $0-$499 for serving as a Consultant for Reistone Biopharma. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seres Therapeutics, Inc. Dr. Rubin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Target RWE. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techlab, Inc. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trellus Health. Dr. Rubin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AGA. Dr. Rubin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Stephanie Freeman Attorney. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Helper Broom LLC. Dr. Rubin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joseph Camarra Attorney.
Brian Talon, PhD Dr. Talon has nothing to disclose.
Fernanda Wajnsztajn, MD An immediate family member of Dr. Wajnsztajn has received personal compensation for serving as an employee of Alexion Pharmaceuticals.
Satyanarayana Vedula, Other Mr. Vedula has nothing to disclose.
Judy Liang, Other Ms. Liang has nothing to disclose.
Cathrin M. Buetefisch, MD, PhD The institution of Dr. Buetefisch has received research support from NIH.
Jazba Soomro, MD Dr. Soomro has nothing to disclose.
Jerry Shen Mr. Shen has nothing to disclose.
Rana Karabudak, MD Dr. Karabudak has nothing to disclose.
Hernan D. Gonorazky, MD Dr. Gonorazky has received personal compensation for serving as an employee of Novartis. Dr. Gonorazky has received personal compensation for serving as an employee of Biogen. Dr. Gonorazky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Pierpaolo Turcano, MD Dr. Turcano has nothing to disclose.
Philippe R. Gaillard, PhD Dr. Gaillard has nothing to disclose.
Ehad Afreen, MD Dr. Afreen has nothing to disclose.
Ameena Rana, MD Dr. Rana has nothing to disclose.
Kathleen C. Somera-Molina, PhD Dr. Somera-Molina has received personal compensation for serving as an employee of Biogen. Dr. Somera-Molina has received stock or an ownership interest from Biogen.
Farren Briggs, PhD The institution of Prof. Briggs has received research support from NIH. The institution of Prof. Briggs has received research support from Michael J. Fox Foundation.
Marta Olive Gadea, MD Mr. Olive Gadea has nothing to disclose.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Sergio Arturo Salazar Marioni No disclosure on file
Phioanh Leia Nghiemphu, MD Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springswork. Dr. Nghiemphu has received research support from Erasca. Dr. Nghiemphu has received research support from Springswork. Dr. Nghiemphu has received research support from Children's Tumor Foundation. Dr. Nghiemphu has received research support from NIH-NCI . Dr. Nghiemphu has received research support from Genentech. Dr. Nghiemphu has received research support from DOD. Dr. Nghiemphu has received research support from Millenium. Dr. Nghiemphu has received research support from GCAR.
Isabella O'Shea Ms. O'Shea has nothing to disclose.
Tariq Nisar Tariq Nisar has nothing to disclose.
Jonathan de Courcy Jonathan de Courcy has nothing to disclose.
Scott Moody Scott Moody has nothing to disclose.
Ole Graff, MD Dr. Graff has received personal compensation for serving as an employee of AbbVie. Dr. Graff has stock in AbbVie.
Arman Cakar Arman Cakar has nothing to disclose.
Kaleb H. Yohay, MD Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
Jia-Yi Wang, MD Dr. Wang has nothing to disclose.
Shirley Triche Shirley Triche has nothing to disclose.
Heidemarie Kletzl Heidemarie Kletzl has received personal compensation for serving as an employee of Hoffmann-La Roche.
Yasmeen Sayed Mohamed, MBBS Dr. Mohamed has nothing to disclose.
Nabila Dahodwala, MD, FAAN Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genetech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Ali Mahta, MD Dr. Mahta has nothing to disclose.
Yarema B Bezchlibnyk Yarema B Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PMT Corporation. Yarema B Bezchlibnyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Yarema B Bezchlibnyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Yarema B Bezchlibnyk has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic.
Glenn Lesser Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cancer Expert Now. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SDP Oncology. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Agios. Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incysus . Glenn Lesser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ONO Pharma. Glenn Lesser has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Glenn Lesser has received research support from Denovo Biopharma. The institution of Glenn Lesser has received research support from Oblato . The institution of Glenn Lesser has received research support from Novocure. The institution of Glenn Lesser has received research support from GBM Agile - GCAR.
Jun Yu, MD Dr. Yu has nothing to disclose.
Divya M. MR No disclosure on file
Lorna Charles, MD Dr. Charles has received personal compensation for serving as an employee of Bristol Myers Squibb. Dr. Charles has stock in Bristol Myers Squibb.
Min Yang Min Yang has nothing to disclose.
Diego Silva Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
David Watson, PhD Dr. Watson has nothing to disclose.
Johnathan Lucas McKay, PhD Dr. McKay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocircuit Technologies. The institution of Dr. McKay has received research support from NIH. The institution of Dr. McKay has received research support from the McCamish Foundation.
Naveed Akhtar, MD, FAAN Dr. Akhtar has nothing to disclose.
Arti Jatwani, PhD Dr. Jatwani has nothing to disclose.
Feride H. Frech, PhD Dr. Frech has received personal compensation for serving as an employee of Eisai Inc.
Alessandro Serra, MD Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Dylan Paul Vincent Blacquiere, MD Dr. Blacquiere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Blacquiere has a non-compensated relationship as a Board of Directors with Canadian Stroke Consortium that is relevant to AAN interests or activities. Dr. Blacquiere has a non-compensated relationship as a Advisory Board Member with Heart and Stroke Foundationof Canada Stroke Best Practice Recommendations that is relevant to AAN interests or activities.
Tu My To Tu My To has received personal compensation for serving as an employee of Genentech. Tu My To has received stock or an ownership interest from Genentech.
Julie Anne Parsons, MD Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis.
Zeynep Ergül Ülger Zeynep Ergül Ülger has nothing to disclose.
Teresita Malapira Teresita Malapira has nothing to disclose.
Harjot Hansra, MD Dr. Hansra has nothing to disclose.
Xing Chen, PhD Dr. Chen has nothing to disclose.
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Deborah Raymond The institution of Ms. Raymond has received research support from NIH.
Shiying Liu The institution of Miss Liu has received research support from NIH/NIGMS. The institution of Miss Liu has received research support from Diana Jacobs Kalman/AFAR Scholarships for Research in the Biology of Aging The Program. The institution of Miss Liu has received research support from Michael J. Fox Foundation.
Michel C. Shamy, MD Dr. Shamy has nothing to disclose.
Shaida Khan, DO Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Chamblee Ryan .
Célina Ducroux, MD Dr. Ducroux has nothing to disclose.
Veronica Lee Mears, Other Dr. Mears has nothing to disclose.
Isabella Canut Ms. Canut has nothing to disclose.
Joshua D. Katz, MD The institution of Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Theraputics. The institution of Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen Pharmaceuticals. The institution of Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. The institution of Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono.
Lindsay Tetreault, MD, PhD Dr. Tetreault has nothing to disclose.
Sienna McNett Ms. McNett has nothing to disclose.
Marc Garbey, PhD Prof. Garbey has stock in Care Constitution, LLC. Prof. Garbey has a non-compensated relationship as a CEO with Care Constitution, LLC that is relevant to AAN interests or activities.
Bryan Franzen, DO Dr. Franzen has nothing to disclose.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Elizabeth Hribal The institution of Miss Hribal has received research support from AbbVie.
Magdy H. Selim, MD, PhD Dr. Selim has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms Inc..
Kayoko Saito, MD, PhD Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapies, Inc./Novartis. Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai (Roche). Dr. Saito has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Gene Therapies, Inc./Novartis. Dr. Saito has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai (Roche). The institution of Dr. Saito has received research support from Biogen.
James McGinley James McGinley has received personal compensation for serving as an employee of Vector Psychometric Group, LLC. An immediate family member of James McGinley has received personal compensation for serving as an employee of UPMC Children's Community Pediatrics. James McGinley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for McGinley Statistical Consulting, LLC. James McGinley has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Cephalalgia (journal). James McGinley has stock in various companies. The institution of James McGinley has received research support from National Headache Foundation.
Thomas Alois Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Matt Quaife Dr. Quaife has received personal compensation for serving as an employee of Evidera.
Tina Duong Tina Duong has received personal compensation for serving as an employee of Roche. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Scholar Rock. Tina Duong has received personal compensation for serving as an employee of Genentech. Tina Duong has received personal compensation for serving as an employee of Novartis. Tina Duong has received personal compensation for serving as an employee of Sarepta. Tina Duong has received personal compensation for serving as an employee of Biogen. Tina Duong has received personal compensation for serving as an employee of Audentes. Tina Duong has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tina Duong has received personal compensation in the range of $0-$499 for serving as a Consultant for Audentes. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Tina Duong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Tina Duong has received research support from biogen. The institution of Tina Duong has received research support from scholar rock.
Akanksha Dave, Other Ms. Dave has nothing to disclose.
Ariyaporn Haripottawekul Miss Haripottawekul has nothing to disclose.
Steven Broglio, PhD Dr. Broglio has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MCW. Dr. Broglio has received personal compensation in the range of $0-$499 for serving as a Consultant for U Calgary. Dr. Broglio has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Montgomery McCracken Walker & Rhoads LLP. The institution of Dr. Broglio has received research support from DoD. The institution of Dr. Broglio has received research support from NCAA.
Shana Lynn Radomski, DO Dr. Radomski has nothing to disclose.
Alexander Paul Ambrosini Mr. Ambrosini has nothing to disclose.
Christina Cramer Christina Cramer has nothing to disclose.
Tsubasa Takizawa, MD,PhD The institution of Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Takizawa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teijin. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Otsuka. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Daiichi Sankyo. Prof. Takizawa has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Prof. Takizawa has received research support from Eli Lilly. Prof. Takizawa has received research support from Tsumura. Prof. Takizawa has received research support from JSPS KAKENHI.
Amanda C. Guidon, MD An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Guidon has received research support from MGFA. The institution of Dr. Guidon has received research support from Project Data Sphere. The institution of Dr. Guidon has received research support from MGNet. The institution of Dr. Guidon has received research support from MGNet. Dr. Guidon has received publishing royalties from a publication relating to health care.
Karan Patel Mr. Patel has nothing to disclose.
Melanie Edward Noel, PhD Dr. Noel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Pediatric Psychology. Dr. Noel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PAIN. Dr. Noel has received research support from CPCoE.
Emanuele Camerucci, MD Dr. Camerucci has nothing to disclose.
Marianne Gerber Marianne Gerber has received personal compensation for serving as an employee of Roche. Marianne Gerber has received stock or an ownership interest from F Hoffmann La Roche .
Tonja Locklear Tonja Locklear has nothing to disclose.
Sophie Binks The institution of Ms. Binks has received research support from Wellcome Trust. The institution of Ms. Binks has received research support from PetSavers. The institution of Ms. Binks has received research support from PetPlan. The institution of Ms. Binks has received research support from NIHR. Ms. Binks has received intellectual property interests from a discovery or technology relating to health care. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ECTRIMS. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with Vetmeduni Wien. Ms. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ANA. Ms. Binks has a non-compensated relationship as a Speaker with Encephalitis Society UK that is relevant to AAN interests or activities.
Jennifer McCombe, MD Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon therapeutics. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon therapeutics. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving as a traveling fellow with Royal College of Canada.
Joep Killestein Joep Killestein has nothing to disclose.
RJ Wirth, PhD RJ Wirth has received personal compensation for serving as an employee of Vector Psychometric Group, LLC.
Michael Vincent Robers, MD Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Robers has received research support from National Multiple Sclerosis Society. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Robers has received research support from Barrow Neurological Foundation.
Niamh Cushen, PT Miss Cushen has nothing to disclose.
Achal K. Srivastava, MD, FAAN Dr. Srivastava has nothing to disclose.
Cole Daniel Stang Mr. Stang has nothing to disclose.
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Shadman Sakib Mozumder Mr. Mozumder has nothing to disclose.
Cynthia Zevallos Cynthia Zevallos has nothing to disclose.
Lindsay Miller Scott, PhD Dr. Miller Scott has nothing to disclose.
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Awadh K. Pandit Awadh K. Pandit has nothing to disclose.
Jason Elenberger Mr. Elenberger has nothing to disclose.
Sibylle Haemmerle, PhD Dr. Haemmerle has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Haemmerle has stock in Novartis Pharma AG.
Veit Rothhammer, MD Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. Rothhammer has received research support from German Research Foundation. The institution of Prof. Rothhammer has received research support from European Research Council.
Guillermo Linares, MD Dr. Linares has nothing to disclose.
Rima Abou-Khalil, PhD Dr. Abou-Khalil has nothing to disclose.
Teresa Gidaro No disclosure on file
Leidys Gutierrez-Martinez, MD The institution of Dr. Gutierrez-Martinez has received research support from American Heart Association.
Narumi Watanabe, MD Dr. Watanabe has nothing to disclose.
Jessica Langbaum, PhD Dr. Langbaum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Langbaum has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Denovo Biopharma. Dr. Langbaum has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Langbaum has received research support from Eli Lilly.
Susan B. Bressman, MD, FAAN The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Rachel Graham Rachel Graham has nothing to disclose.
Sagar S Bachhav, PhD Dr. Bachhav has received personal compensation for serving as an employee of AbbVie Inc, USA. Dr. Bachhav has stock in AbbVie Inc. USA.
Kaya Gloyd Jordan, CRC Ms. Jordan has nothing to disclose.
Colette Ndiba-Markey, Other Mrs. Ndiba-Markey has received personal compensation for serving as an employee of Genesis Research.
Jan Kirschner Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genethon. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jan Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. The institution of Jan Kirschner has received research support from Biogen. The institution of Jan Kirschner has received research support from Novartis. The institution of Jan Kirschner has received research support from Roche.
Yanghong Yang Ms. Yang has nothing to disclose.
Ina Ly, MD An immediate family member of Dr. Ly has received personal compensation for serving as an employee of Enanta Pharmaceuticals. Dr. Ly has received research support from Department of Defense. An immediate family member of Dr. Ly has received intellectual property interests from a discovery or technology relating to health care.
Michael Kurnellas Michael Kurnellas has received personal compensation for serving as an employee of Alector. Michael Kurnellas has received stock or an ownership interest from Alector. Michael Kurnellas has received intellectual property interests from a discovery or technology relating to health care.
Vibhash D. Sharma, MD Dr. Sharma has nothing to disclose.
Tommi Tervonen Tommi Tervonen has received personal compensation for serving as an employee of Evidera.
Gary Raymond Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Stuart McCarter, MD Dr. McCarter has nothing to disclose.
Katherine Nearing, MD Dr. Nearing has nothing to disclose.
Victor Hernan Salinas The institution of an immediate family member of Dr. Salinas has received research support from Veterans Health Administration.
Kamil Taneja Mr. Taneja has nothing to disclose.
Fiifi Duodu, MD Dr. Duodu has nothing to disclose.
Marcus Maurer Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astria. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioCryst. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blueprint. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kalvista. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharvaris. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Regeneron. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Marcus Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ThirdHarmonicBio. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noucor. Marcus Maurer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Septerna. Marcus Maurer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Marcus Maurer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Phavaris. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Marcus Maurer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Marcus Maurer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Daniel B. Hier, MD, MBA, FAAN Dr. Hier has nothing to disclose.
Jon V. Riolo, PhD Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Frederik Clement, Sr., MD Dr. Clement has nothing to disclose.
Michael Kinsman, MD Dr. Kinsman has nothing to disclose.
Azka Shaikh, MD Dr. Shaikh has nothing to disclose.
Inmaculada Alonso García Miss Alonso García has nothing to disclose.
Christopher Edward Uy, MD Dr. Uy has nothing to disclose.
Jorg Windsheimer Jorg Windsheimer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen,BMS,Janssen,Roche,Hexal. Jorg Windsheimer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen,Teva,BMS.
Gordon Jewett, MD Dr. Jewett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Jewett has received research support from ALS Canada. Dr. Jewett has received research support from Canadian Institute of Health Research.
Manish Gehani, PhD,MBBS,Other Dr. Gehani has received personal compensation for serving as an employee of Novartis.
Jose Meca Lallana, MD Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Patrick Adjei, MD,Other,PhD Prof. Adjei has nothing to disclose.
Hani Kushlaf, MD, FAAN Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion AstraZeneca Rare Disease. Dr. Kushlaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Kushlaf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kushlaf has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Elif Gokcal, Jr., MD Mrs. Gokcal has nothing to disclose.
Pamela Song, MD Prof. Song has nothing to disclose.
Gabriella Marie Bognet, Other Ms. Bognet has nothing to disclose.
Eric Faulkner, Other Mr. Faulkner has received personal compensation for serving as an employee of Novartis Gene Therapies.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Andrew Murchison Andrew Murchison has nothing to disclose.
Anneke Van Der Walt, MD Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Van Der Walt has received research support from NHMRC Australia. The institution of Dr. Van Der Walt has received research support from MSRA. The institution of Dr. Van Der Walt has received research support from Roche.
Jaclyn White, MD Dr. White has nothing to disclose.
Kelly A. Mills, MD Dr. Mills has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tilosia. The institution of Dr. Mills has received research support from NINDS. The institution of Dr. Mills has received research support from MJFF. The institution of Dr. Mills has received research support from GKC.
Asad Ahrar, MD Dr. Ahrar has nothing to disclose.
Thanujaa Subramaniam, MD Dr. Subramaniam has nothing to disclose.
Quentin Lesport Mr. Lesport has nothing to disclose.
Tatsuro Misu No disclosure on file
Rebecca Hurst-Davis, Other Ms. Hurst-Davis has received personal compensation in the range of $500-$4,999 for serving as a Medical Advisory Council with CureSMA. Ms. Hurst-Davis has a non-compensated relationship as a Medical Advisory Council member/speaker with CureSMA that is relevant to AAN interests or activities.
Parthasarathy Thirumala, MD, FAAN The institution of Dr. Thirumala has received research support from University of Pittsburgh.
Myrto Trapali, Other Ms. Trapali has received personal compensation for serving as an employee of Evidera.
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Trygve Holmoy, MD Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Norwegian MS Society. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
CL Whichello, PhD Dr. Whichello has received personal compensation for serving as an employee of Evidera.
Yingjie Ding, Other Ms. Ding has received personal compensation for serving as an employee of Genesis Research.
Alexander K. Song, Other Mr. Song has nothing to disclose.
Sarah Grace Ahr, Other Ms. Ahr has nothing to disclose.
Kate M. Essad, MD Dr. Essad has nothing to disclose.
Muhammad Moataz Al Aref Dr. Al Aref has nothing to disclose.
Lei Xu, PhD No disclosure on file
James R. McCullough, Other Mr. McCullough has received personal compensation for serving as an employee of Hoffmann-La Roche Limited. Mr. McCullough has stock in Roche Holding AG.
Sayyeda Zahra, MD Dr. Zahra has nothing to disclose.
Deli Wang, MD, PhD Dr. Wang has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Wang has stock in AbbVie Inc..
Isabel Machín Díaz, Other Miss Díaz has nothing to disclose.
Sai Batchu, Other Mr. Batchu has nothing to disclose.
Thomas Leist, MD, PhD, FAAN Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Leist has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Leist has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Leist has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Seono. Dr. Leist has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Wittness with DHHS HRSA.
Marco Pasi Marco Pasi has nothing to disclose.
Darce Costello, PhD Dr. Costello has nothing to disclose.
Dana Crawford, PhD Dr. Crawford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. The institution of Dr. Crawford has received research support from NIH/NIDDK. The institution of Dr. Crawford has received research support from NIH/NCATS. The institution of Dr. Crawford has received research support from VA. The institution of Dr. Crawford has received research support from NIH/NIGMS. The institution of Dr. Crawford has received research support from NHGRI. The institution of Dr. Crawford has received research support from NIH/NIA. Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving as a Member with NIH Study Section.
Dawn C. Buse, PhD Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Ye Su, DO Dr. Su has nothing to disclose.
Renaud A. Du Pasquier, MD, FAAN Dr. Du Pasquier has nothing to disclose.
Alex MacKenzie The institution of Alex MacKenzie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen.
Thomas L. Davis, MD Dr. Davis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Davis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Parkinson Foundation.
Pranav Gandhi Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
Meghana Karnik-Henry Meghana Karnik-Henry has received personal compensation for serving as an employee of Lundbeck.
Richard Carson No disclosure on file
P.R. Schuurman P.R. Schuurman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. P.R. Schuurman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
Laura De Lima Xavier, MD Dr. De Lima Xavier has nothing to disclose.
Danielle Feng, MD Dr. Feng has nothing to disclose.
Andrew Phillip Huang, MD Dr. Huang has nothing to disclose.
Pallavi Juneja, MD Dr. Juneja has nothing to disclose.
Victoria Reedman, MD Dr. Reedman has nothing to disclose.
Deborah Kathleen Rose, MD Dr. Rose has nothing to disclose.
Sabrina Kristine Tavella, DO Dr. Tavella has nothing to disclose.
Sarah Doebley Miss Doebley has nothing to disclose.
Sofia Eugenia Nicolayevsky, Other Ms. Nicolayevsky has nothing to disclose.
Sanghee Yun, PhD Dr. Yun has nothing to disclose.
Amelia Eisch, PhD The institution of Prof. Eisch has received research support from NIH . The institution of Prof. Eisch has received research support from NASA. Prof. Eisch has received personal compensation in the range of $0-$499 for serving as a Study section member with NIH. Prof. Eisch has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with NASA.
Sheyenne Sheyenne Gillis, RN Miss Sheyenne Gillis has nothing to disclose.
Danielle G. Barber, MD, PhD The institution of Dr. Barber has received research support from NIH.
Sudipa Biswas, MD Dr. Biswas has nothing to disclose.
Aarushi Suneja, MD Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Amira Salim Miss Salim has nothing to disclose.
Zubair Ahmed, MD Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Ignacio Mata Ignacio Mata has nothing to disclose.
Elise Ruth Hennessy, MD Dr. Hennessy has nothing to disclose.
Ghislain N'Dah-Sekou Ghislain N'Dah-Sekou has nothing to disclose.
Jonathan Stokes, Other Mr. Stokes has nothing to disclose.
Abdelmonem Siddiq Abdelmonem Siddiq has nothing to disclose.
Ellen Dennehy Ellen Dennehy has received personal compensation for serving as an employee of Eli Lilly. Ellen Dennehy has stock in Eli Lilly.
Oralee Johnson Varnado, PhD Miss Varnado has received personal compensation for serving as an employee of Eli Lilly and Company. Miss Varnado has stock in Eli Lilly and Company.
Lori B. Chibnik Lori B. Chibnik has nothing to disclose.
Anastasia Vishnevetsky, MD The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext).
Phoebe Jiang, PhD Dr. Jiang has received personal compensation for serving as an employee of Biogen. Dr. Jiang has stock in Biogen.
Catherine Walsh Imossi Ms. Imossi has nothing to disclose.
John R. Sims, MD Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
Neha Kapur Neha Kapur has received personal compensation for serving as an employee of Lundbeck.
Mohammad Mojtahed Mohammad Mojtahed has nothing to disclose.
Aram Zabeti, MD Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Zabeti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Zabeti has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Biogen. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Zabeti has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen . Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Zabeti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Divya Ganugapati Miss Ganugapati has nothing to disclose.
Teresa Gidaro Dr. Gidaro has nothing to disclose.
Abdoreza Ghoreishi No disclosure on file
Mohammad Bagher Abar No disclosure on file